US20050084516A1 - Process for making gel films - Google Patents

Process for making gel films Download PDF

Info

Publication number
US20050084516A1
US20050084516A1 US10/824,689 US82468904A US2005084516A1 US 20050084516 A1 US20050084516 A1 US 20050084516A1 US 82468904 A US82468904 A US 82468904A US 2005084516 A1 US2005084516 A1 US 2005084516A1
Authority
US
United States
Prior art keywords
film
temperature
molten composition
gel
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/824,689
Other languages
English (en)
Inventor
Arthur Ballard
Christopher Sewall
James Modliszewski
William Blakemore
Peter Riley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FMC Corp
Original Assignee
FMC Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FMC Corp filed Critical FMC Corp
Priority to US10/824,689 priority Critical patent/US20050084516A1/en
Publication of US20050084516A1 publication Critical patent/US20050084516A1/en
Assigned to FMC CORPORATION reassignment FMC CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MODLISZEWSKI, JAMES J., BALLARD, ARTHUR D., BLAKEMORE, WILLIAM R., RILEY, PETER J., SEWALL, CHRISTOPHER J.
Priority to US11/954,958 priority patent/US20080089934A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/238—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from seeds, e.g. locust bean gum or guar gum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/737—Galactomannans, e.g. guar; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Definitions

  • the present invention is directed to a process for making homogeneous, thermoreversible gel films comprising the steps of: (i) heating, hydrating, mixing, solubilizing, and, optionally, de-aerating a film forming composition in an apparatus providing sufficient shear, temperature and residence time to form a homogeneous molten composition, wherein the temperature is at or above the solubilizing temperature of said composition; (ii) feeding the molten composition into at least one of a mixer, pump or devolatilizer; and (iii) cooling the homogeneous molten composition at or below its gelling temperature to form said gel films.
  • the present invention is also directed to various products made from such films, such as the gel films themselves, soft capsules, solid dosage forms and delivery systems.
  • compositions containing, for example, hydrocolloids form highly viscous solutions that make formation of hydrated films difficult to obtain.
  • the present invention provides a process for preparing high solids, low moisture films from such highly viscous solutions.
  • the present invention is directed to a process for making homogeneous, thermoreversible gel films comprising the steps of: (i) heating, hydrating, mixing, solubilizing, and, optionally, de-aerating a re film forming composition in an apparatus providing sufficient shear, temperature and residence time to form a homogeneous molten composition, wherein the temperature is at or above the solubilizing temperature of said composition; (ii) feeding the molten composition into at least one of a mixer, pump or devolatilizer; and (iii) cooling the homogeneous molten composition at or below its gelling temperature to form said gel films.
  • the present invention is directed to the homogeneous, thermoreversible, gel films made from the above process.
  • the present invention is directed to a process for making soft capsules comprising the steps of: (i) heating, hydrating, mixing, solubilizing, and, optionally, de-aerating a film forming composition in an apparatus providing sufficient shear, temperature and residence time to form a homogeneous molten composition, wherein the temperature is at or above the solubilizing temperature of the composition; (ii) feeding the molten composition into at least one of a mixer, pump or devolatilizer; (iii) cooling the molten composition to or below the solubilizing temperature of the molten composition to form the homogeneous, thermoreversible gel film; and (iii) making soft capsules from the gel film.
  • the present invention is directed to soft capsules made by the above process.
  • the present invention is directed to a process for making a solid dosage form comprising a fill material encapsulated by a homogeneous, thermoreversible gel film comprising the steps of: (i) preparing the homogeneous, thermoreversible gel film in accordance with the above process; and (ii) encapsulating the fill material in the gel film.
  • the present invention is also directed to solid dosage forms made from the process.
  • the present invention is directed to a process for preparing a homogeneous gel film delivery system comprising an active substance and a homogeneous, thermoreversible gel film, comprising the steps of: (i) preparing the molten composition in the above process; (ii) adding an effective amount of an active substance prior to or after formation of the molten composition: and (iii) cooling the molten composition containing the active substance at or below its gelling temperature to form the gel films containing the active substance.
  • the present invention is also directed to delivery systems made by the process.
  • the present invention is directed to a process for making homogeneous, thermoreversible gel films comprising the steps of: (i) heating, hydrating, mixing, solubilizing, and, optionally de-aerating a film forming composition in an apparatus providing sufficient shear, temperature and residence time to form a homogeneous molten composition, wherein the temperature is at or above the solubilizing temperature of the composition; and (ii) cooling the homogeneous molten composition at or below its gelling temperature to form said gel films.
  • the present invention is also directed to dosage forms, solid forms and delivery systems made by the process.
  • Figure 1 is schematic of a process of the present invention to make films and soft capsules using a Stephan processor together with an extruder.
  • the extruder is optional in this figure, and the Stephan processor can be replaced with, e.g., a Ross mixer.
  • this figure refers to "LV Guar” (low viscosity guar), this invention is not limited thereby.
  • Figure 2 is a schematic of a process of the present invention to make films and soft capsules using a fluid mixing apparatus such as in Figure 3 together with an extruder.
  • the extruder is optional in this figure.
  • Figure 3 is a partially broken away, side elevational view of the fluid mixing apparatus for mixing first and second fluids with steam that can be used in the process of Figure 2.
  • Figure 4 is another version of the schematic of Figure 2 showing the film coming out of the extruder proceeding to an encapsulation apparatus.
  • a first embodiment of the present invention is a process for making homogeneous, thermoreversible gel films comprising the steps of: (i) heating, hydrating, mixing, solubilizing, and, optionally, de-aerating a film forming composition in an apparatus capable of providing sufficient shear, temperature and residence time to form a molten composition, wherein the temperature of the molten mass is maintained at or above its solubilizing temperature; (ii) feeding said molten composition into at least one of a mixer, pump or devolatilizer; and (iii) cooling said molten composition at or below is gelling temperature to form said gel films.
  • the process of the present invention provides homogeneous, thermoreversible gel films having, e.g., a relatively high solids content.
  • homogeneous film defines films that, to the naked eye, are visually uniform and free of defects such as lumps, cracks, particles that are undissolved that should be dissolved, non-uniform distribution of insoluble particles, etc. "Fish eyes” (mixed liquid and solid states) or “gel balls” (non-uniform gel structure) would not meet the definition of "homogeneous” as used herein.
  • the gel films of the present invention are homogeneous, thermoreversible gel films. They can be cast and used in a variety of applications as cast films or in further processing.
  • thermaloreversible film defines a film that has a melting temperature.
  • the melting temperature is the temperature or temperature range over which the gel film softens or flows.
  • gel films refer to a thin membrane formed from, e.g., structured hydrocolloid.
  • the gel-forming composition is characterized by a gel temperature, the temperature below which the molten mass of the gel composition must be cooled to form a self-supporting structure.
  • a molten mass can be cast hot and allowed to cool, as well as dry to further concentrate the solids (controlled moisture removal) until a gel film is formed by the gel composition.
  • the melt temperature of a thermoreversible gel film is higher than its gel temperature.
  • the "solubilizing temperature” means the temperature at which the composition becomes homogeneous. Solubilizing refers to the act of fully dissolving all the soluble components in the molten composition and all insoluble materials are uniformly dispersed.
  • the components in the film forming system can be any components found in film forming compositions that form high solids, low moisture gel films when heated and hydrated and that form homogeneous, thermoreversible gel films.
  • such compositions can contain thermoreversible hydrocolloids.
  • thermoreversible hydrocolloids that can be used in the present invention to form thermoreversible gel films include polysaccharides such as: carrageenan including iota carrageenan, kappa carrageenan, kappa-2 carrageenan; xanthan gum; polymannan gums (e.g., glucomannan gums and galactomannan gums) such as locust bean gum, konjac, tara gum, cassia gum, guar gum (e.g.
  • low viscosity guar gum low viscosity guar gum
  • alginates including propylene glycol alginate and monovalent salts of alginates such as potassium and sodium
  • pullulan propylene glycol alginate and monovalent salts of alginates such as potassium and sodium
  • pullulan propylene glycol alginate and monovalent salts of alginates such as potassium and sodium
  • gellan including high and low-acyl gellan
  • dextran including high and low-acyl gellan
  • pectin and combinations thereof.
  • the carrageenans can be modified, less than fully modified or unmodified.
  • kappa-2 carrageenan has a molar ratio of 3:6-anhydrogalactose-2-sulfate (3:6-AG-2-S) to 3:6-anhydroglactose (3:6-AG) content of 25 to 50%
  • iota carrageenan has a molar ratio of 3:6AG-2S to 3:6AG content of 80 to 100%
  • kappa carrageenan has a molar ratio of 3:6AG-2S to 3:6AG content less than that for kappa-2 carrageenan.
  • kappa carrageenan from Eucheuma cottonii a commonly known and used seaweed source for kappa carrageenan
  • iota carrageenan from Spinosum a commonly known and used seaweed source for iota carrageenan
  • kappa-2 carrageenan comprises a ratio of kappa (3:6-AG) repeating units to iota (3:6-AG-2-S) repeating units between 1.0 to 3.0:1, more particularly, 1.5 to 3.0:1 (more particularly depending on the desired application).
  • the molar ratio of 3:6AG-2S to 3:6AG content in these carrageenans holds regardless of its degree of modification and precursor content (e.g, mu and nu repeating units).
  • the homogeneous, thermoreversible gel film made by the process of the present invention can optionally contain at least one of a plasticizer, a second film former, a bulking agent and a pH controlling agent depending on their application.
  • plasticizers examples include polyols such as glycerin, sorbitol, maltitol, lactitol, corn starch, fructose, polydextrose, solubilized oils and polyalkylene glycols such as propylene glycol and polyethylene glycol.
  • plasticizers can generally be used in an amount of at least 5%, more preferably, at least 10%, more preferably, at least 20%, more preferably, at least 30% by weight of all the components including water in the dry film if a gel film having more elasticity is desired; e.g., films to be used to make soft capsules.
  • the plasticizer can be present in an amount of 0% to 20% by weight of all the components in the dry film. It is possible that the gel film of the invention contains no plasticizer at all.
  • the carrageenan can have a viscosity of 19 cps or less, more particularly less than 10 cps, at 75 °C when measured 0.10 molar sodium chloride solution containing 1.5% of such carrageenan by weight based on the total weight of the composition. This viscosity test can be performed using a Brookfield LVF (Brookfield Engineering Laboratories, Inc.) viscometer using Spindle #1 at 60 r.p.m. and determining the viscosity after six revolutions.
  • Brookfield LVF Brookfield Engineering Laboratories, Inc.
  • Examples of the second film former that can be used in the present invention include at least one of a starch, starch derivative, starch hydrozylate, cellulose gum, hydrocolloid, an alkylcellulose ether or a modified alkyl cellulose ether.
  • Examples of the hydrocolloids are those listed above. Others include non-gelling carrageenans such as lambda carrageenan.
  • An example of an alkylcellulose ether that can be used in the present invention is hydroxyethylcellulose.
  • Examples of modified alkylcellulose ethers that can be used in the present invention include hydroxypropylcellulose and hydroxypropylmethylcellulose.
  • the primary film former can be the only film former in the gel film. When the gel films of the present invention contain second film formers, the primary film former can be present in an amount of at least 10%, at least 40%, at least 60% or at least 80% by weight of the total amount of film formers in the gel film.
  • modified starch includes such starches as hydroxypropylated starches, acid-thinned starches, and the like.
  • modified starches that can be used in the present invention include Pure Cote? B760, B790, B793, B795, M250 and M180, Pure-Dent? B890 and Pure-Set? B965, all available from Grain Processing Corporation of Muscatine, Iowa, and C AraTex? 75701, available from Cerestar, Inc.
  • modified starches are products prepared by the chemical treatment of starches, for example, acid treatment starches, enzyme treatment starches, oxidized starches, cross-bonding starches, and other starch derivatives. It is preferred that the modified starches be derivatized wherein side chains are modified with hydrophilic or hydrophobic groups to thereby form a more complicated structure with a strong interaction between side chains.
  • the amount of the bulking agent to be used in the present invention is generally in the amount of 0 to 20% by weight of the dry film, but more can be used, if desired, for example, at least 20%, more preferably, at least 30% of the dry film depending on the application.
  • starch, starch derivatives and starch hydrozylates can be multifunctional. That is, in addition to being used as bulking agents, they can be used as second film formers. When such are used as bulking agents and second film formers, they are generally used in an amount of at least 10%, preferably, at least 20%, by weight of the gel film.
  • Examples of the pH controlling agent to be used in the present invention include bases such as hydroxides, carbonates, citrates and phosphates.
  • the pH controlling agent can be chosen as the source of added beneficial cations such as potassium.
  • the pH controlling agent can be used to improve the stability of the gel film.
  • the amount of the pH controlling agent is generally in the amount of 0 to 4%, preferably, 0 to 2%.
  • the dry films made from the gels of the present invention have been found to have, for example, a break force of at least at least 1,000 grams, at least 2,500 grams, at least 4,000 grams, at least 5,000 grams, at least 6,000 grams, as determined by using a Texture Analyzer TA-108S Mini Film Test Rig.
  • wet films made by the process of the present invention have yielded low break force strength (e.g., 250-320g), but have produced strong dried films having the break force strengths mentioned above.
  • the gel films of the present invention have been found to have a solids content of at least 50%, at least 60%, at least 70%, at least 80% and at least 90% of all components in the gel film. It is understood that up to 15%, 10%, 5% water may remain strongly associated with the solids in the gel film.
  • Dry film thicknesses generally used for soft capsules are in the range of 0.5 to 3.0mm, more preferably, 0.8 to 1.2 mm.
  • the films of the present invention can contain nonthermoreversible gums.
  • nonthermoreversible gums should be present in an amount of less than 50% by weight of the thermoreversible film former, preferably, less than 40% more preferably, less than 30%.
  • nonthermoreversible gums include crosslinked or partially crosslinked gums such as calcium set (e.g., crosslinked) pectins or alginates. Calcium reactive alginates and pectins, as well as their less refined forms, are considered as thermoreversible gums in the absence of divalent cations.
  • the gel films of the present invention are generally made from a process utilizing an apparatus that enables sufficiently high shear, temperature (above the gelling temperature) and residence time so as to provide a homogeneous molten mass of the composition and formation of the gel upon cooling. This is generally accomplished in the apparatus by heating, hydrating, mixing, solubilizing and optionally de-aerating the composition.
  • Such apparatus include but are not limited to Ross mixers, Stephan processors, conventional jet cookers, extruders and the fluid mixing apparatus as set forth in Figure 3 . Ross mixers, Stephan processors, extruders and conventional jet cookers are readily available commercially.
  • the molten mass Prior to cooling, the molten mass can be fed to at least one of a pump, mixer or devolatilizer.
  • An extruded molten mass can also be directed to a film forming or shaping device (e.g. spreader box, as used in a capsule forming machine) that aids in the uniform casting of a continuous film, or, through a die that allows a direct formation of a film from the molten mass delivery equipment. Care must be taken to maintain the molten mass above the initiation of restricted flow/gel structure formation. Insulated and pre-heated (to maintain proper temperatures) transfer hoses may be used to insure molten mass flow until desired gel film formation is initiated on the casting rolls or at other film formation points, such as an extruder (restrictive flow, film forming device) or die.
  • a film forming or shaping device e.g. spreader box, as used in a capsule forming machine
  • Additional processing methods can force (by pressure) the molten mass through the transfer hoses mentioned above. Additional insulation can help maintain molten mass temperatures through the use of a Teflon disk initially placed upon the molten mass surface immediately after removing the mixing device.
  • the feeder hoses can be introduced to the heat controlled molten mass feeder (casting) boxes located on a capsule machine either directly to the boxes or through an optional modification of the feeder boxes which introduces a top half enclosure/cover that helps maintain molten mass temperatures within the feeder box, reduces moisture loss, and maintains uniform (center) filling of the box during the extended process of forming films for capsules.
  • molten mass temperatures can be used to form films for capsules. This includes, but is not limited to extrusion of the molten mass through dies/orifices into films that: can be immediately fed into the capsule forming apparatus, stored at temperatures that maintain proper film conditions (to form capsules) until needed, or dried to desired moisture, solids and texture levels, until needed.
  • Such dried films have the property of re-absorbing water (water is introduced by any means) throughout its gel film matrix and can be rehydrated when needed, for example, to make soft capsules or other solid forms. Moisture is introduced to the film until a desired moisture content and strength/texture is reached that will allow the film's introduction into a capsule machine to make soft capsules.
  • a typical process for using such with hydrocolloids is as follows.
  • the components of the film forming composition are fed into the Stephan processor and heated (while agitating) to a temperature, which provides solubility to the components above their gel temperature.
  • the material can then be processed into a gel film or as a molten mass. Further processing can be completed on this material while utilizing appropriate equipment to allow it to develop its final form.
  • FIG. 3 illustrates a fluid mixing apparatus 10 .
  • the fluid mixing apparatus 10 is arranged to mix steam 2 with a first fluid or slurry 4 and a second fluid or slurry 6 to produce a molten mass or slurry mixture 8 .
  • the fluid mixing apparatus 10 comprises a first housing 20 having a first inlet 22 through which the steam 2 enters the housing 22 , a nozzle end 24 from which the steam 2 exits the housing 20 , and a nozzle valve or stem 26 disposed at the nozzle end 24 .
  • An actuator means 30 is connected to the first housing 20 for controlling the exit rate or exit pressure of the first fluid 2 at the nozzle end 24 .
  • the actuator means 30 may be of the type manufactured by Fisher Controls U.S.A.
  • the fluid mixing apparatus 10 further comprises a second, mixing housing 40 coupled to the first housing 20 at the nozzle end 24 of the first housing 20 .
  • the second housing 40 includes a second inlet 42 through which the first fluid 4 enters the second housing 40 , and a third inlet 44 through which the second fluid 6 enters the second housing 40 .
  • the inlets 42 and 44 are disposed downstream of the first inlet 22 .
  • the second inlet 42 and third inlet 44 are disposed in a common plane and spaced apart radially from each other, most preferably directly opposite (i.e., 180o apart) about the central axis Y of the mixing apparatus 10 .
  • the second housing 40 defines a generally cylindrical mixing chamber 52 that in turn defines a flow passage extending along the axial length of the mixing chamber 52 from an entry end 54 of the mixing chamber 52 to an exit end 56 of the chamber 52 .
  • the nozzle valve 26 is movable by the actuator 30 between seated and unseated positions at the entry end 54 to control the flow rate of steam 2 into the mixing chamber 52 .
  • the nozzle end 24 of the first housing 20 directs the steam 2 into the entry end 54 of the mixing chamber 52 .
  • the second inlet 42 and the third inlet 44 radially direct the first fluid 4 and second fluid 6 , respectively, into the mixing chamber 52 .
  • the steam 2 , first fluid 4 and second fluid 6 are mixed in the mixing chamber 52 to form a molten mass or mixture 8 which exits the mixing chamber 52 .
  • the molten mass 8 then may be shaped into a shaped article or formed into a film, such as by casting the mixture 8 onto a cooling drum or by passing the mixture 8 through an extruder.
  • the molten mass composition may be then fed directly into at least one of a pump, mixer or devolatilizer. Then, the molten mass is cooled down to or below the gelling temperature of the composition to form the gel film.
  • solubilizing temperature be greater than the boiling point of the homogeneous molten composition at atmospheric pressure and that the heating, hydrating, mixing and solubilizing is conducted above atmospheric pressure.
  • a preferred process comprises feeding the molten composition directly into a mixer, deareated, depressurized and pumped prior to cooling to or below the molten composition's gelling temperature.
  • One device that contains at least one of a pump, mixer and devolatilizer is an extruder.
  • An extruder is preferred device for devolatilizing and thereby concentrating the solids of the molten composition prior to cooling.
  • Extruders that can be used in the present invention include single or dual barrel extruders with inlet devices sufficient to allow transfer of the fully or partially hydrated composition without incurring a temperature drop during the transfer. Once the compositional material achieves its targeted solids content and the temperature is maintained above its gel temperature, the resulting molten mass can be used as previously described.
  • the molten mass need not necessarily reach homogeneity in step (i). That is, homogeneity of the molten mass can be obtained prior to or after feeding the molten composition into at least one of the mixer, pump or devolatilizer provided the molten mass reaches homogeneity prior to gelling.
  • the present invention is a process for making soft capsules comprising the steps of: (i) heating, hydrating, mixing, solubilizing, and, optionally, de-aerating the film forming composition in the apparatus capable of providing sufficient shear, temperature and residence time to form a molten composition, wherein the temperature is at or above the solubilizing temperature of the molten mass; (ii) feeding the molten composition into an extruder to form a high solids, low moisture, homogeneous, thermoreversible gel film; and (iii) making soft capsules from the gel film.
  • the gel film and its components, as well as the apparatus and extruder that can be used, are as set forth above.
  • the process for making soft capsules of the invention includes the use of any conventional encapsulating apparatus once the gel films discussed are prepared, e.g., a conventional rotary die apparatus or concave stamping die.
  • a conventional rotary die apparatus or concave stamping die For example, once the molten mass of the present invention has been made, it can be cast onto drums, cooled and then fed between rotary encapsulation dies where the films are heated again, filled, sealed and cut.
  • WO 98/42294 see WO 98/42294.
  • the use of the high shear apparatus disclosed above allows the molten mass to be sufficiently hydrated, extruded, applied to drums as they are cooling and then fed into conventional encapsulating apparatus for filling, sealing and cutting. This continuous type process can be used to eliminate the step of having to reheat fully gelled and cooled films for capsule preparation.
  • Hard capsules refer to those solid forms that are conventionally used, e.g., in the pharmaceutical industry whereby two half shells are formed, a fill material, usually a powder, is placed in the shells and the two halves are placed together to form the hard capsule.
  • the process for making such hard capsules would typically involve dipping metal pins or bars into the molten composition of the present invention and allowing the gel film to form around the pins. The gel films are dried and then removed from the pins.
  • the fill materials for the hard capsules can be any fill materials commonly used in such dosage forms. Generally, the fill materials can be liquids or solids such as powders. The fill materials can be a pharmaceutical ingredient, agricultural ingredient, nutraceutical ingredient, veterinary ingredient, food, cosmetic ingredient, flavorant, etc.
  • the solid form may also encapsulate a powder, tablet, caplet, microcapsule or capsule in accordance with known techniques.
  • encapsulating a hard capsule with the gel film of the invention would allow for safety seal/tamper resistant capabilities.
  • gel films of the invention can contain added components that can create solid dosage forms having immediate release, controlled, enteric or delayed release capabilities. Definitions of "immediate release”, “delayed release” and “enteric” can be found in the U.S. Pharmacopeia and are incorporated herein by reference.
  • the gel films of the present invention can be used in a process for preparing a homogeneous gel film delivery system comprising an active substance and a homogeneous, thermoreversible gel film, comprising the steps of: (i) preparing the molten composition; (ii) adding an effective amount of an active substance thereto; and (iii) cooling said molten composition containing said active substance at or below its gelling temperature to form said gel films containing said active substance.
  • the active substance can include at least one of an oral care agent, a breath freshening agent, a pharmaceutical agent, a nutraceutical agent, a salivary stimulant agent, a vitamin, a mineral, a coloring agent, a sweetener, a flavorant, a fragrance, a food.
  • Process for making homogeneous, thermoreversible gel films of the present invention also comprises the steps of: (i) heating, hydrating, mixing, solubilizing, and, optionally, de-aerating a film forming composition in an apparatus providing sufficient shear, temperature and residence time to form a homogeneous molten composition, wherein the temperature is at or above the solubilizing temperature of the composition; and (ii) cooling the homogeneous molten composition at or below its gelling temperature to form said gel films.
  • This process can be used to make dosage forms, solid forms and delivery systems as mentioned above.
  • An apparatus especially suited for this process is the Ross mixer and, when making soft or hard capsules, can be used to provide the gel film directly to the capsule making machine or, if desired, to rollers for use at a later time. All of the materials described herein can be used in this process.
  • the following example uses the fluid mixing apparatus of FIG. 3 to make the gel films of the present invention.
  • Parts A and Parts B were pumped from separate holding tanks at ambient temperature, as two separate streams 4, 6, into two different inlet ports 42, 44 which fed the steam injection fluid mixing apparatus device 10.
  • the two individual streams 4, 6 were combined at the interface of the steam in the mixing zone 52 of the fluid mixing apparatus 10.
  • the separate solutions of Part A and Part B were readily pumped into the fluid mixing apparatus 10 and mixed with steam 2.
  • the steam 2 was introduced to the mixing zone at a pressure of 120 psi.
  • the resulting molten mass or slurry mixture 8 flowed out of the exit port 56 of the fluid mixing apparatus 10.
  • the mixture 8 was poured onto a smooth surface and drawn down to form a homogeneous film 9.
  • the molten mass 8 was collected from the outlet 56 then cast using a draw down bar, with a gap set at 3 mm, onto a stainless steel metal plate.
  • the initial films 9 or "fresh films” were collected. Portions of the fresh films 9 were dried by placing them in a 40oC forced air oven. Break force was measured on the cast and dried film strips using a Texture Analyzer TA-108S Mini Film Test Rig. The percent solids were determined by measuring the difference between the initial weight of the fresh film and the final weight of the dried films.
  • thermometer was inserted into the molten mass 8.
  • the material 8 was allowed to cool under room temperature conditions. After each degree of cooling, the thermometer was removed from the material 8. When a small, temporary indentation was observed in the surface of the mass 8, this temperature was recorded.
  • the thermometer was re-inserted into the mass 8, which was allowed to cool further.
  • the thermometer was removed and re-inserted at every degree of cooling until such a time as a permanent indentation formed in the mass 8, such that the indentation did not refill.
  • the temperature at which the permanent indentation formed was recorded.
  • the gel temperature reported was the range between the two recorded temperatures.
  • the components in the Tables below are further defined below in Tables 5 and 6.
  • Example No. 1A 1B 1C 1D 1E Part A (%) Carrageenan D 0.0 0.0 0.0 0.0 8.9 Carrageenan C 7.0 8.4 8.9 0.0 0.0 Carrageenan B 0.0 0.0 0.0 8.9 0.0 Glycerin 26.5 31.8 33.5 33.5 33.5 Part B (%) Starch 16.4 19.7 20.7 20.7 20.7 Water 50.0 40.0 36.9 36.9 36.9 Mixing chamber 107 107 108 108 temp. (° C.) Outlet temp (° C.) 101 102 102 102 102 Viscosity cP (@ 7300 5200 48000 50000 12400 95° C.) pH 7.3 Not tested 8 6.4 6.7 % solids 53 54 65 61 53 Gel temp.
  • Example No. 2A 2B 2C 2D 2E Part A (%) Carrageenan C 2.7 3.2 3.2 4.0 0.0 Carrageenan B 0.0 0.0 0.0 0.0 0.0 4.0 PGA 3.3 3.9 3.9 4.9 4.9 Glycerin 22.4 26.5 26.5 33.5 33.5 Part B (%) KOH 0.0 0.0 0.1 0.0 0.0 K 2 CO 3 0.0 0.0 0.0 0.3 0.3 Starch 13.9 16.4 16.4 20.7 20.7 Water 57.8 50.0 49.9 36.6 36.6 Mixing chamber 108 107 108 107 108 temp.
  • the film former can be a combination of hydrocolloids, such as carrageenan and PGA. Additionally, salts can be added to influence film properties such as strength, gel temperature and pH.
  • Example No. 3A 3B 3C Part A (%) Carrageenan E 0 4.0 4.2 Carrageenan B 4.3 0.0 0.0 ULV guar 4.6 4.9 5.1 Glycerin 33.5 33.5 27.0 Sorbitol 0.0 0.0 8.1 Part B (%) Starch 20.7 20.7 21.8 Water Mixing chamber temp. (° C.) 108 108 108 Outlet temp (° C.) 102 102 102 Viscosity cP (@ 95° C.) 7900 7800 69000 pH 6.5 5.6 5.5 % solids 57 57 55 Gel temp. (° C.) 60-65 >100 >100 wet film strength (grams) 460 3402 921 dry film strength (grams) 5299 6587 9234
  • Table 3 shows that the film former can be a combination of hydrocolloids such as carrageenan and guar.
  • Example No. 4A 4B Part A (%) Carragennan G 0.0 8.9 Carrageenan F 8.9 0.0 Glycerin 33.5 33.5 Part B (%) Starch B790 20.7 20.7 Water 36.9 36.9 Mixing chamber temp. ° C.) 108 108 Outlet temp (° C.) 102 102 Viscosity cP (@ 95° C.) >100K 8400 PH 7.5 8 % solids 46 49 Gel temp. (° C.) >100 >100 wet film strength (grams) 722 360 dry film strength (grams) 1095 4213
  • Table 4 illustrates that PES and upgraded PES can be processed in the mixing apparatus 10.
  • the upgraded PES provides some advantages, such as a lower outlet viscosity, and results in a higher strength dry film.
  • Tables 5 and 6 provide further descriptions of the components specified in this Example.
  • Carrageenan PES Kappa An alkali processed, non- FMC F clarified, processed Corporation Eucheuma seaweed product (containing kappa-carra- geenan) of Kappaphycus al- verezii( Eucheuma cottonii) with low di- valency.
  • the films made in accordance with this invention can be used in conventional capsule making equipment previously used for making gelatin capsules.
  • the Stephan UMC5 processor is a laboratory scale-mixing device which provided suitable high shear mixing, heating, and deaerating of the formulations which were cast as films in the laboratory.
  • a suitable batch size used with the Stephan UMC5 processor was 1500 grams.
  • aqueous starch dispersion was prepared by dissolving any salts/buffers and pH modifiers in deionized water. The starch and/or maltodextrin (M100) were added and mixed until dissolved/dispersed. Pure Cote® B760 and B790 starches are available from the Grain Processing Corporation of Muscatine, Iowa.
  • a hydrocolloid mixture was prepared in the Stephan UMC5 processor by premixing the plasticizers until uniform, and adding the preblended dry hydrocolloids portionwise while mixing for about 30 seconds at 200 rpm after each addition.
  • Sorbitol Special and glycerin were used as plasticizers.
  • Sorbitol Special is an aqueous solution of sorbitol and sorbitol anhydrides at 76% solids supplied by SPI Polyols, Inc. (New Castle, DE).
  • the starch dispersion was added to the non-aqueous hydrocolloid mixture and mixed at 300 rpm for 5 minutes.
  • the mechanical agitation was increased to 2100 rpm and the mixture was heated to 85°C to 95°C with mixing.
  • the target temperature was achieved, the mixture was stirred for 30 minutes, then the sample was held under vacuum (50-60 bars) with continued agitation for an additional 45 minutes.
  • a small portion of the sample was set aside and refrigerated usually overnight prior to measurement of gel/melt properties and solids using an Atago E series hand held refractometer (Gardco, Pompano Beach, FL).
  • the melt temperature was determined by placing a small chunk of the refrigerated gel on a wire string stand held within a test tube so that the chunk does not contact the wall of the test tube.
  • the test tube was covered with aluminum foil with a small hole to allow measurement of the gel temperature using a digital Tempermeter probe.
  • the test tube was immersed in the heating bath so that the chunk is below the surface of a hot water bath at approximately 100 o C.
  • a silicone oil bath was used for samples that had melt temperatures above 90 o C.
  • the melt temperature was recorded when the gelled sample became wet in appearance, softened and could be stirred (a temperature range was noted). Once the sample had melted, the test tube was transferred to a second beaker containing cold tap water (15 o C). The temperature probe was used to record the temperature as the sample was cooled and to probe the sample surface to determine whether the sample had begun to gel. The gel temperature was the temperature upon cooling where the sample no longer flowed to fill in an indentation made by the probe.
  • the hot sample was then cast, using a draw down bar with a gap set at 3mm clearance, onto 177 mm by 177 mm by 5 mm metal plates which were pre-sprayed with PAM (lecithin) to facilitate easy removal of film material.
  • the gel coated plates were covered to avoid loss of moisture from the cast film.
  • Cast films were typically refrigerated (less than 8 o C) for at least one-half hour prior to removal of the film for testing. Refrigeration is not required for film formation.
  • Dried film strips were prepared by drying the coated plates in a 40 °C forced air/fan oven. Films dried 2 hours at 40 o C gave an intermediate solids of about 60%, while films dried overnight at 40 o C typically gave solids of 80% or higher.
  • Test properties were measured at room temperature (approximately 20 °C) unless otherwise specified. The percent of solids of the dried film was determined between the cast film at its formulated solids level and the dried film by difference in weight. Break force (BF) was measured on the cast and dried film strips using a Texture Analyzer TA-108S Mini Film Test Rig.
  • Maltrin M100 was obtained from Grain Processing Corporation, Pure-Cote B760 was obtained from Grain Processing Corporation, Sorbitol Special was obtained from SPI Polyols and Glycerin was obtained from VWR (EP/USP grade).
  • Table 8 shows compositions and film properties for formulations prepared using low viscosity guar ULV 50 in combination with kappa-2 carrageenans.
  • Cgn A is a kappa-2 carrageenan as defined herein that was obtained as an alkali processed, clarified extract of Gigartina skottsbergii , essentially haploid (gametophyte) plants. Minor levels (under 5% total) of lambda- and theta-carrageenans from diploid (tetrasporophyte) plants were also present.
  • Cgn A has a low divalent cation content and low potassium cation content as shown in Table 7.
  • Cgn B is a kappa-2 carrageenan that was obtained as an alkali processed, clarified extract of a mixture of Gigartina skottsbergii and Sarcothalia crispata , primarily haploid (gametophyte) plants. About 10-20% (total) of lambda- and theta-carrageenans from diploid (tetrasporophyte) plants were also present.
  • the properties of the kappa-2 carrageenans are shown in Table 7. Viscosity of an aqueous solution at 1.5 wt % solids was measured at 75 o C using a Brookfield LVF viscometer at appropriate speeds and spindles. The properties of 2% water gels prepared using 2 wt% of samples Cgn A-B (#1) without added cations, (#2) with 0.2 wt% added KCl and (#3) with 0.2% added KCl and 0.2% CaCl 2 , respectively, were characterized using a TXTM Texture Analyzer. Gels were tested at 25 o C and the break force (in grams) and the penetration (in millimeters) was recorded.
  • Example 1-2 demonstrates that a 55 to 45 %by weight mixture of guar with kappa-2 carrageenan has increased strength compared to guar alone (Example 2-1).
  • Example 2-4 demonstrates the desirability of maintaining process temperatures for the molten mass above the gel temperature, as Example 2-5 provided finished (dried) gel strengths, when cast at 95 o C, at least 28% higher than a film cast at 87 o C (Example 2-4).
  • the lower gel strength values are reflective of potential pre-gelation during film formation causing a relatively lower gel strength. All films were free of syneresis upon storage and maintained their relative flexibility.
  • Viscosities were generally found to be at or near the maximum for the test equipment and conditions used. Therefore, use of supplementary equipment with the initial hydration/activation apparatus can provide additional shear and solids concentration effects while maintaining process temperatures well above their high solids set/gel temperatures (> 100 o C.).
  • An example of this supplementary equipment, but not limited to, would be an extruder type device sufficient to maintain adequate temperatures and shear necessary to provide the homogeneous mixing and solids concentrations necessary to allow either shaping of the molten mass for direct film or capsule casting or further allow shaping of the molten mass into a desired form such as a film either for use as a film or further processed into other forms and functions.
  • KCl addition (Example 3-3) increased the gel temperature and also the 40% solids gel strength. Further, KCl addition and varying ratios of film forming ingredients will control cast film strength and gel melt temperatures. When kappa carrageenans are used in combination with low viscosity guar of the invention, control of cation divalency desirably prevents/minimizes gel hardening and brittleness.
  • Table 10 reports the compositions and properties of films formed using low viscosity guar ULV50 with kappa and iota carrageenans.
  • Cgn C is an alkali processed clarified kappa carrageenan extract of Kappaphycus alverezii ( Eucheuma cottonii ).
  • Cgn D is an alkali processed clarified iota carrageenan extract of Eucheuma denticulatum ( Eucheuma spinosum ) with low divalency. Both Cgn C and Cgn D have low divalency.
  • Table 11 presents compositions and properties of films formed using mixtures of guar with potassium alginates and/or carrageenans.
  • Alginates are polyuronate copolymers comprising mannuronate (M) and guluronate(G) units.
  • KAHG is a potassium alginate where the alginate has a high level of G units and is extracted from Laminaria hyperborean .
  • KAHM is a potassium alginate where the alginate has a high level of M units and is extracted from Lessonia nigrescens .
  • Table 12 reports compositions and properties of gel films prepared using blends of low viscosity guar ULV50 with sodium alginates.
  • Protanal® LFR 5/60, Protanal® LF 20/40 and Protanal® SF 120 RB are sodium alginates available from FMC Corporation (Philadelphia, PA).
  • Ex-4-7 Ex 4-8 Ex 4-9
  • Ingredient (g) Water 836.3 836.3 836.3 LFR 5/60 40.5 0 0 LF 20/40 0 40.5 0 SF120 RB 0 0 30 GUAR ULV50 49.5 49.5 45 B760 220.8 220.8 220.8 M100 0 0 15.0 SORBITOL SP 264.4 264.4 264.4 GLYCERIN 88.2 88.2 88.2 Total weight 1500.0 1500.0 1500.0 Temp, ° C.* 90 94 93 VISCOSITY, MPAS* 31,650 >50,000 >50,000 Gel, ° C. 50 NA NA Melt, ° C.
  • Table 13 presents compositions and gel films formed from low viscosity guar ULV 50 in combination with propylene glycol alginate.
  • Protanal® ester BV4830 and Protanal® ester SLF3 are propylene glycol alginates available from FMC BioPolymer (Philadelphia PA).
  • Table 14 lists compositions and properties of gel films prepared using propylene glycol alginate and kappa carrageenan.
  • Protanal® ester BV4830 is a propylene glycol alginates available from FMC Corporation (Philadelphia, PA).
  • HEC is hydroxyethylcellulose.
  • Kappa carrageenan was an alkali processed, clarified extract of Kappaphycus alaverei ( Euchema cottonii ).
  • Table 15 reports compositions and film properties for kappa-2 carrageenan used in combination with propylene glycol alginate and potassium alginate.
  • the kappa-2 carrageenan was an alkali processed, clarified extract of a mixture of Gigartina skottsbergii and Sarcothalia crispata , primarily haploid (gametophyte) plants.
  • potassium cations are supplied by the potassium alginate.
  • the potassium cations promote carrageenan double helix formation at a temperature that allows the carrageenan to form its gel film structure.
  • the additional strength and lower processing viscosity is believed to be due to the higher level of propylene glycol alginate.
  • Cgn A was obtained as an alkali processed, kappa-2 carrageenan clarified extract of Gigartina skottsbergii , essentially haploid (gametophyte) plants and recovered by precipitation with alcohol. Minor levels (under 5% total) of lambda- and theta-carrageenans from diploid (tetrasporophyte) plants were also present.
  • Cgn B was obtained by dissolving Cgn A in water, and recovered by alcohol precipitation and drying. Samples of different molecular weights were obtained by reaction of the dissolved carrageenan with an oxidizing agent to yield Cgn C-F. Sodium hydroxide was added to samples Cgn C-E after the oxidation step and prior to alcohol precipitation to control the pH of the resulting product.
  • the properties of the kappa-2 carrageenans are shown in Table 16. Viscosity of an aqueous solution at 1.5 wt % solids was measured at 75 o C using a Brookfield LVF viscometer at appropriate speeds and spindles. The properties of 2% water gels prepared using 2 wt% of samples Cgn A-F (#1) without added cations, (#2) with 0.2 wt% added KCl and (#3) with 0.2% added KCl and 0.2% CaCl, respectively, were characterized using a TXTM Texture Analyzer. Gels were tested at 25 o C and the break force (in grams) and the penetration (in millimeters) was recorded.
  • Cgn A-F are examples of the kappa-2 carrageenans that can be used in the present invention.
  • Example 6-2 and Example 6-1 the viscosity of the molten mass at processing temperature (13,700 mPas and 4000 mPas, respectively) was controlled by decreasing the molecular weight of Cgn D to CgnE (expressed as viscosity of 24 mPas and 14 mPas, respectively) with an insignificant impact on film properties.
  • Example 6-2, 6-3 and 6-4 The melt temperature of the cast material increased (Examples 6-2, 6-3 and 6-4) as the solids content was increased for a given formulation.
  • the gel temperature increased with increasing solids until the gel temperature approached the temperature of the molten mass.
  • Kappa-2 carrageenan was obtained as an alkali processed, clarified extract of a mixture of Gigartina skottsbergii and Sarcothalia crispata , primarily haploid (gametophyte) plants. About 10-20% (total) of lambda- and theta-carrageenans from diploid (tetrasporophyte) plants was also present. The extract was recovered and subsequently ion exchanged to provide a kappa-2 carrageenan with low divalency. Properties of the low divalent cation kappa-2 carrageenans (Cgn G-J) are shown in Table 18. Cgn G-J are considered to be within the scope of the invention.
  • Ex 7-1 Ex 7-2
  • Ex 7-3 Ex 7-4
  • Ingredients (g) Water 834.7 834.7 834.7 834.7 834.7 Cgn J 75 0 75 75 Cgn I 0 75 0 0 KCl 0 0 9.0 9.0 STARCH B790 0 0 0 227.3 M-100 227.3 227.3 227.3 0 SORBITOL SP 274.9 274.9 274.9 GLYCERIN 91.7 91.7 91.7 91.7 Temp, ° C.* 89 87 87 87 VISCOSITY, MPAS* 5800 5800 6250 10,300 Solids (estimated) 40% 40% 41% 40% Melt, ° C. 45-48 43 66-71 70 Gel, ° C.
  • the ion exchanged kappa-2 carrageenans (I and J) combined with polyols and maltodextrin (as a bulking agent) provided a relatively weaker cast gel film with negligible break force at 40% solids. This is believed to be due to insufficient amounts of potassium cations that are desired to more fully promote carrageenan double helix formation (i.e., gelling) at temperatures that allow the carrageenan to be the primary structuring agent.
  • Examples 7-1 and 7-2 are gel films having relatively lower melt and gel temperatures. Even though gelation potential is not maximized (due to lower potassium levels), Examples 7-1 and 7-2 show a break force of 3468 and 3697, respectively.
  • Example 7-3 demonstrates the effect of potassium ion addition to the structure formed by the kappa-2 carrageenan in Cgn J. Cast strength, although soft, provided sufficient strength for film removal from the casting plate. Structure development by Cgn J, with the addition of potassium ions, is confirmed by the increase in melt and gel temperatures in Example 7-3 as compared to Example 7-1. Break force of the dried film remained comparable to Examples 7-1 and 7-2.
  • Example 7-4 demonstrates the effect of replacing maltodextrin in Example 7-3 by a modified starch (B790). While viscosity was increased, the gel and melt temperatures remained relatively similar to Example 7-3 which contained the maltodextrin.
  • the cast film strength of Example 7-4 was also relatively equal to Example 7-3.
  • the dried film strength of Example 2-4 was more than doubled as compared to Example 7-3. This clearly indicates the structural synergy between the starch and kappa-2 carrageenan, when both are present with potassium cations (i.e., gelling ions for kappa-2 carrageenan). Potassium ions may be provided by direct addition of inorganic salts, organic salts, or combinations thereof or contained within additional ingredients.
  • kappa-2 carrageenan containing residual processing salts can promote the desired gel formation conditions that maximizes gel structure and starch synergy.
  • a homogeneous kappa-2 carrageenan/starch gel structure was formed by casting the molten mass at sufficiently high temperatures to prevent pre-gelation.
  • Example 7-5 was prepared to have equivalent cation content with example 5-1. Both samples show the same gel melt properties.
  • the higher molecular weight of Cgn E (14 cps) in Example 5-1 provided more structural support to the gel film as compared to Cgn H (6 cps) in Example 7-5, as is shown by the higher break force of the dried film.
  • the higher dried film strength of the Example 7-7 shows that use of modified starch in combination with low molecular weight kappa-2 carrageenan provides overall film structure and indicates complexation of kappa-2 carrageenan with the starch.
  • a heated and mixed composition e.g., any of those in Examples 1-7, is formed into a film in a conventional polymer film casting machine by transferring a controlled thickness of the molten composition onto a temperature controlled rotating drum operated at a temperature such that the film formed is suitable for handling and processing in subsequent operations.
  • films Downstream from the film forming operation, films are fed through a series of rollers to counter-rotating dies in a conventional gelatin capsule machine to form, cut and fill capsules of various sizes.
  • two film surfaces are brought into contact under fusing conditions (i.e., time under sufficient local pressure and local temperature to fuse them together).
  • the formed capsules are discharged for further processing. Recovered capsules have sufficient mechanical strength to withstand handling, packaging, and storage conditions.
  • Soft gel capsules (7.5 oval) containing mineral oil (Formula A below) were produced using a Technophar SGM1010 soft capsule machine with 7.25 inch long by 4 inch diameter dies. Preparation of the molten mass used to form the capsule shell was as follows: 11.35 lbs of kappa-2-carrageenan was added to a charge of 33.89 lbs of glycerin in a Ross DS40 jacketed vacuum mixer and dispersed at maximum speed for 5 minutes. An additional 11.35 lbs of kappa-2 carrageenan was added to the mixture and dispersed an additional 5 minutes. A premix of 50 lbs of PureCote B790 modified starch in 94.1 lbs of deionized water was then charged to the mixer.
  • the mixer hood was closed and a 26 inch vacuum was pulled to remove air.
  • the contents were mixed for 30 minutes with the planetary mixer at maximum speed and the disperser at 1/3 maximum speed.
  • the vacuum was locked in and the contents of the mixer were then mixed while heating to 90 o C by applying low pressure steam ( ⁇ 10 psig) to the mixer jacket.
  • the disperser speed was gradually increased to 2/3 maximum while maintaining the molten mass at a temperature of at least 90 o C for 45 minutes.
  • the molten mass was dispensed using a pressurized plate to urge the molten mass to flow as needed from the Ross mixer through a temperature controlled, electrically heated ( ⁇ 125 o C) flexible hose to the covered spreader box.
  • the cast films formed in the spreader box were continuous and even.
  • the films were transported by rollers to the capsule forming dies where capsules were formed, filled with mineral oil and sealed.
  • the capsule sealing temperature was 62 o C and the sealing pressure was ⁇ 2 bars.
  • the ability to seal was improved as the thickness of the ribbon was decreased from 0.28 inches to 0.16 inches.
  • Capsules were tunnel dried for 72 hours at 80 o F and 19% RH.
  • the integrity of the capsule seal remained good after drying.
  • the cast film made from this formulation was dark amber and cloudy with a slight seaweed odor.
  • the break force of the film (0.3 mm in thickness) was 310 g at 58% solids.
  • the breakforce of the film after drying overnight at 40 o C and 40% RH ( ⁇ 80% solids) was 3309 g. See A in Table 21 below.
  • Additional soft capsules (Formula B below) encapsulating mineral oil were produced according to the above process and equipment using a second formulation comprising 39.7 lbs of Sorbitol SP, 59.5 lbs of glycerin, 19.6 lbs of sodium ion exchanged kappa-2 carrageenan, 44.6 Lbs of PureCote B760 starch and 92.6 pounds of water.
  • the Sorbitol SP was added in the starch/water premix.
  • Films produced using this formulation were odorless, transparent and a medium color.
  • the as-cast film had a thickness of 0.6 mm and a break force strength of 263 g at 55% solids.
  • the capsules were evaluated for weight, film thickness for each half of the capsule, and burst strength. Burst strength was measured by compressing the capsule to failure. The compression probe had a speed of 1 mm/sec. Ten capsules were tested for each condition. The shell strength is reported as the capsule burst strength with the seam horizontally positioned. The seam strength was measured for 10 capsules with the seam vertically positioned. Results are shown in Table 21. Both kappa-2-carrageenen films were flexible as indicated by the burst distance and produced a strong capsule seal as indicated by a capsule burst strength that was approximately the same for the capsule shell and the capsule seam and that the capsule did not fail at the seam but at the tip on the seam (away from the point of pressure).

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Extrusion Moulding Of Plastics Or The Like (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Seasonings (AREA)
  • Processing And Handling Of Plastics And Other Materials For Molding In General (AREA)
US10/824,689 2003-04-14 2004-04-14 Process for making gel films Abandoned US20050084516A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US10/824,689 US20050084516A1 (en) 2003-04-14 2004-04-14 Process for making gel films
US11/954,958 US20080089934A1 (en) 2003-04-14 2007-12-12 Process for making gel films

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US46278503P 2003-04-14 2003-04-14
US46279403P 2003-04-14 2003-04-14
US46261703P 2003-04-14 2003-04-14
US46279203P 2003-04-14 2003-04-14
US46275803P 2003-04-14 2003-04-14
US46279303P 2003-04-14 2003-04-14
US46272103P 2003-04-14 2003-04-14
US46278303P 2003-04-14 2003-04-14
US10/824,689 US20050084516A1 (en) 2003-04-14 2004-04-14 Process for making gel films

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/954,958 Continuation US20080089934A1 (en) 2003-04-14 2007-12-12 Process for making gel films

Publications (1)

Publication Number Publication Date
US20050084516A1 true US20050084516A1 (en) 2005-04-21

Family

ID=33304300

Family Applications (3)

Application Number Title Priority Date Filing Date
US10/824,860 Active 2028-02-20 US7807194B2 (en) 2003-04-14 2004-04-14 Homogeneous, thermoreversible gel film containing kappa-2 carrageenan and soft capsules made therefrom
US10/824,689 Abandoned US20050084516A1 (en) 2003-04-14 2004-04-14 Process for making gel films
US11/954,958 Abandoned US20080089934A1 (en) 2003-04-14 2007-12-12 Process for making gel films

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10/824,860 Active 2028-02-20 US7807194B2 (en) 2003-04-14 2004-04-14 Homogeneous, thermoreversible gel film containing kappa-2 carrageenan and soft capsules made therefrom

Family Applications After (1)

Application Number Title Priority Date Filing Date
US11/954,958 Abandoned US20080089934A1 (en) 2003-04-14 2007-12-12 Process for making gel films

Country Status (10)

Country Link
US (3) US7807194B2 (de)
EP (8) EP1628643B9 (de)
JP (8) JP2006526057A (de)
KR (4) KR20060003350A (de)
BR (7) BRPI0409329A (de)
CA (5) CA2522296A1 (de)
IL (1) IL171291A (de)
MX (4) MXPA05011028A (de)
PL (1) PL1628643T3 (de)
WO (9) WO2004091538A2 (de)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050196436A1 (en) * 2004-03-02 2005-09-08 Arjnarong Chantranukul Blends of different acyl gellan gums and starch
US20050196437A1 (en) * 2004-03-02 2005-09-08 Bednarz Christina A. Hard capsules
US20080138402A1 (en) * 2006-11-17 2008-06-12 Zhixin Li Highly inhibited starch fillers for films and capsules
US20090217462A1 (en) * 2008-02-08 2009-09-03 Holzhauer Fred Consumer product packets with enhanced performance
US20090249562A1 (en) * 2008-04-02 2009-10-08 Mark Robert Sivik Fabric color rejuvenation composition
US20100061180A1 (en) * 2008-09-05 2010-03-11 United States Gypsum Company Efficient wet starch preparation system for gypsum board production
US8262820B2 (en) 2006-04-28 2012-09-11 United States Gypsum Company Method of water dispersing pregelatinized starch in making gypsum products

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7887838B2 (en) * 2002-01-18 2011-02-15 Banner Pharmacaps, Inc. Non-gelatin film and method and apparatus for producing same
BRPI0409329A (pt) * 2003-04-14 2006-04-25 Fmc Corp processo para fabricar pelìculas de gel termorreversìveis, homogêneas, pelìcula homogênea, termorreversìvel, de sólidos altos, umidade baixa, processo para fabricar cápsulas moles, cápsulas moles, processo para fabricar uma forma de dosagem sólida, forma sólida, processo para preparar uma sistema de liberação de pelìcula de gel homogênea, e, sistema de liberação
WO2004096283A1 (ja) * 2003-05-02 2004-11-11 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo ソフトカプセル皮膜及びソフトカプセル
DE102005023258A1 (de) * 2004-11-16 2006-11-23 Fan Separator Gmbh Drehtrommel zur aeroben Erwärmung rieselfähiger Feststoffe
SE530184C2 (sv) 2005-12-23 2008-03-18 Kjell Stenberg Bioadhesiv farmaceutisk filmkomposition innehållande lågviskösa alginater
CN101346135A (zh) * 2005-12-27 2009-01-14 莫诺索尔克斯有限公司 用于活性剂递送的已调节pH的膜
EP3095447B1 (de) 2006-02-03 2021-11-24 OPKO Renal, LLC Behandlung von vitamin-d-insuffizienz und -mangel mit 25-hydroxyvitamin d2 und 25-hydroxyvitamin d3
EP2024436A1 (de) * 2006-06-06 2009-02-18 Fmc Corporation Kappa-2 carrageenan-zusammensetzungen und daraus hergestellte produkte
US20070281065A1 (en) * 2006-06-06 2007-12-06 Modliszewski James J Kappa-2 carrageenan composition and products made therefrom
PT2037936E (pt) 2006-06-21 2014-09-04 Opko Renal Llc Método de tratamento e prevenção do hiperparatiroidismo secundário
US8900558B2 (en) 2006-06-30 2014-12-02 Colgate-Palmolive Company High fluoride ion oral care composition and method for maintaining anticaries activity
JP2008072915A (ja) * 2006-09-19 2008-04-03 Dhc Co フィルム状食品
KR100846494B1 (ko) * 2006-09-26 2008-07-17 삼성전자주식회사 헬리코박터 파일로리의 표적 서열을 증폭하기 위한프라이머 세트, 상기 프라이머 세트를 이용하여 헬리코박터파일로리를 검출하는 방법 및 상기 프라이머 세트를포함하는 헬리코박터 파일로리를 검출하는 키트
CA2682752C (en) * 2007-04-05 2015-07-07 University Of Kansas Rapidly dissolving pharmaceutical compositions comprising pullulan
US8900629B2 (en) 2007-04-05 2014-12-02 University Of Kansas Rapidly dissolving pharmaceutical compositions comprising pullulan
US11752158B2 (en) 2007-04-25 2023-09-12 Eirgen Pharma Ltd. Method of treating vitamin D insufficiency and deficiency
US20100144684A1 (en) 2007-04-25 2010-06-10 Proventiv Therapeutics, Inc. Method of Safely and Effectively Treating and Preventing Secondary Hyperparathyroidism in Chronic Kidney Disease
CN104523707B (zh) 2007-04-25 2022-08-26 欧普科Ip 控股Ii 有限公司 包含维生素d化合物和蜡质载体的口服控释组合物
JP5871447B2 (ja) * 2007-11-30 2016-03-01 花王株式会社 Ｇｉｐ分泌抑制剤
KR101685031B1 (ko) 2008-04-02 2016-12-09 사이토크로마 인코포레이티드 비타민 ｄ 결핍 및 관련 장애에 유용한 방법, 조성물, 용도 및 키트
EP2108677A1 (de) 2008-04-10 2009-10-14 Swiss Caps Rechte und Lizenzen AG Thermoplastische Stärkemassen
PL2303034T3 (pl) * 2008-07-25 2017-03-31 Tic Gums Inc Zamienniki gumy arabskiej w: 1) drażetkowaniu, konfekcjonowaniu, adhezji i powlekaniu; 2) kapsułkowaniu aromatów i jadalnych folii; oraz 3) litografii
ITMI20081450A1 (it) * 2008-08-04 2010-02-05 Biofarmitalia Spa Pellicola solida a rapida dissoluzione nei liquidi
CA2737880A1 (en) * 2008-09-26 2010-04-01 Sankyo Co., Ltd. Method for manufacturing soft capsule and apparatus for manufacturing the same
FR2946227B1 (fr) * 2009-06-03 2011-07-22 Ds France Sas Enrobage de saucisse comprenant a la fois un derive de cellulose et un galactomannane.
JP4822299B2 (ja) * 2009-06-19 2011-11-24 富士カプセル株式会社 ソフトカプセル及びその製造方法
EP2475394B1 (de) * 2009-09-10 2019-03-20 DuPont Nutrition USA, Inc. Nahtlose alginatkapseln
WO2011119287A1 (en) * 2010-03-26 2011-09-29 Dow Global Technologies Llc Melt-extruded film
WO2011123476A1 (en) 2010-03-29 2011-10-06 Cytochroma Inc. Methods and compositions for reducing parathyroid levels
BR122020023630B1 (pt) * 2010-07-19 2021-09-08 Procaps S.A Cápsula mole de gelatina contendo cápsulas ou outras formas de dosagem sólida em seu interior
US9277976B2 (en) 2011-01-24 2016-03-08 Leonard G. Lorch Dental floss
US9277977B2 (en) 2011-01-24 2016-03-08 Leonard G. Lorch Dental floss
US10206765B2 (en) 2011-01-24 2019-02-19 Leonard G. Lorch Dental floss
EP2700415B1 (de) 2011-04-20 2016-11-30 Suheung Co., Ltd. Nicht-tierische weichkapselhüllenzusammensetzung mit verbesserter auflösung und hüllenhärte
US8877259B2 (en) 2012-02-09 2014-11-04 Mary Kay Inc. Cosmetic formulation
US9320297B2 (en) * 2012-03-22 2016-04-26 Lemniscate Innovations Llc Spherification/reverse spherification automated and integrated system and method
WO2014063358A1 (en) * 2012-10-26 2014-05-01 Dow Global Technologies Llc Aqueous fragrance release gels
JP6389237B2 (ja) * 2013-03-15 2018-09-12 パセオン ソフトジェルズ インコーポレイティド 非ゼラチン性腸溶性軟質カプセル
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
NL2010552C2 (en) 2013-04-02 2014-10-06 Paxtree Ltd Composition as auxiliary means for oral medication.
US20160304761A1 (en) * 2013-12-05 2016-10-20 Empire Technology Development Llc Thermostatic materials, methods of making, and uses thereof
CR20170085A (es) 2014-08-07 2017-04-25 Opko Ireland Global Holdings Ltd Terapia adjuntiva con 25-hidroxi vitamina d
US20170119680A1 (en) * 2015-10-30 2017-05-04 R.P. Scherer Technologies, Llc Extended release film-coated capsules
KR20180123100A (ko) 2016-03-28 2018-11-14 옵코 아일랜드 글로벌 홀딩스 리미티드 비타민 d 치료 방법
KR101973057B1 (ko) * 2017-04-13 2019-04-26 주식회사 케이티앤지 화장품용 캡슐 및 이의 제조 방법
KR101874512B1 (ko) * 2017-06-29 2018-07-04 농업회사법인(주)강림오가닉 들기름의 식물성 오메가-3에 비타민씨를 함유시킨 혼합물을 식물성 연질 캡슐형으로 제조하는 방법 및 들기름의 식물성 오메가-3에 비타민씨를 함유시킨 혼합물을 식물성 연질 캡슐형으로 제조한 건강기능식품
US11896720B2 (en) 2017-09-26 2024-02-13 Captek Softgel International Orally available articles containing at least one stabilized supplement therein
US10711119B2 (en) 2018-01-10 2020-07-14 Cp Kelco Aps Carrageenan-based compositions for films and capsules
GB201903090D0 (en) * 2019-03-07 2019-04-24 Cambridge Entpr Ltd Plant based functional materials
CN114306272A (zh) * 2019-06-12 2022-04-12 江苏艾兰得营养品有限公司 一种植物软胶囊及其制备方法与用途
CN111388442A (zh) * 2020-03-24 2020-07-10 广州普正生物科技有限公司 一种凝胶糖果型植物软胶囊
CA3193396A1 (en) 2020-09-22 2022-03-31 Cory G. Miller Chitosan-containing coating compositions
KR102294072B1 (ko) * 2020-11-19 2021-08-26 (주)알피바이오 식물성 츄어블 연질캡슐용 조성물 및 이를 통해 형성된 식물성 츄어블 연질캡슐
WO2022159807A1 (en) 2021-01-25 2022-07-28 Dupont Nutrition Biosciences Aps A stabilizer composition comprising microcrystalline cellulose
FR3122575A1 (fr) * 2021-05-05 2022-11-11 Gabrielle De La Goublaye De Nantois Capsules molles cosmétiques
WO2023008567A1 (ja) * 2021-07-30 2023-02-02 三生医薬株式会社 カプセル剤皮組成物およびこれを用いたカプセル剤
CN117897472A (zh) * 2021-08-27 2024-04-16 联合利华知识产权控股有限公司 膜和胶囊
CN117999335A (zh) * 2021-08-27 2024-05-07 联合利华知识产权控股有限公司 膜和胶囊
WO2023025768A1 (en) * 2021-08-27 2023-03-02 Unilever Ip Holdings B.V. Films and capsules
WO2023025728A1 (en) * 2021-08-27 2023-03-02 Unilever Ip Holdings B.V. Films and capsules
WO2023025649A1 (en) * 2021-08-27 2023-03-02 Unilever Ip Holdings B.V. Films and capsules
WO2023025917A1 (en) * 2021-08-27 2023-03-02 Unilever Ip Holdings B.V. Films and capsules
WO2023072546A1 (en) * 2021-10-25 2023-05-04 Unilever Ip Holdings B.V. Films and capsules
WO2024080269A1 (ja) * 2022-10-11 2024-04-18 アリメント工業株式会社 咀嚼性ソフトカプセル剤

Citations (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2802000A (en) * 1953-08-13 1957-08-06 Nat Starch Products Inc Ungelatinized cold water soluble starch ethers
US2813093A (en) * 1953-06-10 1957-11-12 Nat Starch Products Inc Ungelatinized tertiary amino alkyl ethers of amylaceous materials
US2825727A (en) * 1954-05-19 1958-03-04 Nat Starch Products Inc Ungelatinized starch products of improved properties and method of making the same
US2876217A (en) * 1956-12-31 1959-03-03 Corn Products Co Starch ethers containing nitrogen and process for making the same
US3058827A (en) * 1960-02-09 1962-10-16 Eastman Kodak Co Dialdehyde starch as gelatin hardener
US3094517A (en) * 1958-12-29 1963-06-18 Marine Colloids Inc Process for treating a polysaccharide of seaweeds of the gigartinaceae and solieriaceae families
US3176003A (en) * 1961-08-15 1965-03-30 Marine Colloids Inc Selective extraction of hydrocolloid fractions from sea plants
US3329509A (en) * 1959-12-01 1967-07-04 Ile Des Produits Lifine Soc Ci Food wrapping membrane
US3378546A (en) * 1965-03-03 1968-04-16 American Maize Prod Co Hydroxypropyl starch ether
US3499962A (en) * 1967-08-24 1970-03-10 Nat Starch Chem Corp Encapsulation of water insoluble materials
US3505110A (en) * 1967-01-18 1970-04-07 Penick & Ford Ltd Sugar products prepared from hydroxypropylated starch
US3607394A (en) * 1969-05-29 1971-09-21 Felix Joseph Germino Novel pregelatinized starches and process for preparing same
US3865603A (en) * 1972-07-17 1975-02-11 Nat Starch Chem Corp Modified starch-extended gelatin compositions
US3956173A (en) * 1974-07-05 1976-05-11 Hercules Incorporated Preparation of gels based on carrageenan
US3962482A (en) * 1975-03-24 1976-06-08 Uniroyal, Ltd. Clear, elastic, water gels based on carrageenan
US4009291A (en) * 1974-03-25 1977-02-22 General Foods Corporation Cold water soluble stable bulked starch
US4026986A (en) * 1975-05-22 1977-05-31 The Dow Chemical Company Capsule shell
US4096327A (en) * 1977-01-05 1978-06-20 Fmc Corporation Modified kappa-carrageenan
US4129134A (en) * 1975-04-14 1978-12-12 Philip Morris Incorporated Smoking article
US4276320A (en) * 1980-01-25 1981-06-30 Fmc Corporation Compositions and method for preparing dessert gels
US4443486A (en) * 1980-04-09 1984-04-17 Fmc Corporation Modified extractive of Eucheuma cottonii seaweed and composition containing same
US4600439A (en) * 1982-10-12 1986-07-15 Roquette Freres Composition and process for coating paper and cardboard process for preparing the compositions and paper and cardboard so obtained
US4615897A (en) * 1985-02-25 1986-10-07 Nabisco Brands, Inc. Cold water soluble gelatin
US4626288A (en) * 1985-01-10 1986-12-02 National Starch And Chemical Corporation Starch derivatives forming reversible gels
US4632848A (en) * 1981-06-23 1986-12-30 Roquette Freres Composition and process for forming a temporary protective coating on an article and article so-protected
US4643894A (en) * 1984-07-24 1987-02-17 Colorcon, Inc. Maltodextrin coating
US4738724A (en) * 1983-11-04 1988-04-19 Warner-Lambert Company Method for forming pharmaceutical capsules from starch compositions
US4795642A (en) * 1986-05-01 1989-01-03 Pharmacaps, Inc. Gelatin-encapsulated controlled-release composition
US4828841A (en) * 1984-07-24 1989-05-09 Colorcon, Inc. Maltodextrin coating
US4935243A (en) * 1988-12-19 1990-06-19 Pharmacaps, Inc. Chewable, edible soft gelatin capsule
US5002934A (en) * 1986-11-24 1991-03-26 Van Den Bergh Foods Co., Division Of Conopco, Inc. Aqueous gel comprising carrageenan
US5051304A (en) * 1986-12-18 1991-09-24 Societe Anonyme: Mero Rousselot Satia Microcapsules based on gelatin and polysaccharides and process for obtaining same
US5089307A (en) * 1989-05-23 1992-02-18 Mitsubishi Rayon Co., Ltd. Edible film and method of making same
US5224989A (en) * 1991-11-18 1993-07-06 Eva Likarova Film-forming dispersion for a protective coating of drug and food containing articles and objects
US5264223A (en) * 1990-03-29 1993-11-23 Japan Elanco Company, Ltd. Hard capsule for pharmaceutical drugs and method for producing the same
US5334640A (en) * 1992-04-08 1994-08-02 Clover Consolidated, Ltd. Ionically covalently crosslinked and crosslinkable biocompatible encapsulation compositions and methods
US5342626A (en) * 1993-04-27 1994-08-30 Merck & Co., Inc. Composition and process for gelatin-free soft capsules
US5431917A (en) * 1992-10-08 1995-07-11 Japan Elanco Company, Ltd. Hard capsule for pharmaceutical drugs and method for producing the same
US5451673A (en) * 1993-04-23 1995-09-19 The United States Of America As Represented By The Secretary Of Agriculture Films fabricated from mixtures of pectin and starch
US5484598A (en) * 1992-08-18 1996-01-16 R.P. Scherer Corporation Soft gelatin medicament capsules with gripping construction
US5525368A (en) * 1989-02-10 1996-06-11 Alko Group Ltd. Degraded polysaccharide derivatives and foodstuffs containing same
US5549983A (en) * 1996-01-22 1996-08-27 Alliedsignal Inc. Coflow planar fuel cell stack construction for solid electrolytes
US5554385A (en) * 1990-11-28 1996-09-10 R. P. Scherer Corporation High amylose starch substituted gelatin capsules
US5569466A (en) * 1995-05-17 1996-10-29 R. P. Scherer Corporation Fill compositions for soft elastic gel capsules
US5587412A (en) * 1992-03-31 1996-12-24 National Starch And Chemical Investment Holding Corporation Esterified starch composition
US5614217A (en) * 1995-06-07 1997-03-25 R.P. Scherer Corporation Capsule shell formulation to produce brittle capsules
US5646206A (en) * 1993-04-23 1997-07-08 The United States Of America As Represented By The Secretary Of Agriculture Films fabricated from mixtures of pectin and poly(vinyl alchohol)
US5672699A (en) * 1995-09-06 1997-09-30 National Starch And Chemical Investment Holding Corporation Process for preparation of hydrophobic starch derivatives
US5726008A (en) * 1996-09-18 1998-03-10 Eastman Kodak Company Photographic elements with improved vehicles
US5756123A (en) * 1994-12-01 1998-05-26 Japan Elanco Co., Ltd. Capsule shell
US5804243A (en) * 1994-12-23 1998-09-08 Cpc International Inc. Process for making low-fat, cake donuts
US5811388A (en) * 1995-06-07 1998-09-22 Cibus Pharmaceutical, Inc. Delivery of drugs to the lower GI tract
US5817323A (en) * 1993-06-28 1998-10-06 R.P. Scherer Corporation Soft gelatin capsule shell compositions
US5820259A (en) * 1996-07-30 1998-10-13 Q-Jet Dsi, Inc. Dual control mixing jet cooker
US5932639A (en) * 1996-05-06 1999-08-03 National Starch And Chemical Investment Holding Corporation Maltodextrin-based adhesives
US5945126A (en) * 1997-02-13 1999-08-31 Oakwood Laboratories L.L.C. Continuous microsphere process
US5976586A (en) * 1997-03-10 1999-11-02 Lawrence Foods Glaze composition with vegetable gums
US6030641A (en) * 1997-06-03 2000-02-29 Uni Colloid Kabushiki Kaisha Sustained release capsule and method for preparing the same
US6063915A (en) * 1998-07-30 2000-05-16 Hercules Incorporated Carrageenan compositions and methods for their production
US6066368A (en) * 1997-12-30 2000-05-23 National Starch And Chemical Investment Holding Corporation Starch esters as moisture vapor barrier coatings
US6099876A (en) * 1994-10-11 2000-08-08 Yissum Research Development Co. Of The Hebrew University Of Jerusalem Temperature-stable liquid cells
US6143324A (en) * 1998-02-03 2000-11-07 Cerestar Holdings B.V. Free-flowable directly compressible starch as binder, disintegrant and filler for compression tablets and hard gelatine capsules
US6146570A (en) * 1998-03-20 2000-11-14 Rhodia Inc. Process for producing extruded hydrocolloid granules
US6210709B1 (en) * 1999-03-24 2001-04-03 Elementis Specialties, Inc. Flexible gelatin free encapsulation material useful for pharmaceuticals, paint balls and other formulations
US6214376B1 (en) * 1998-08-25 2001-04-10 Banner Pharmacaps, Inc. Non-gelatin substitutes for oral delivery capsules, their composition and process of manufacture
US6326028B1 (en) * 1997-10-31 2001-12-04 Monsanto Company Alginate and gellan gum as tablet coating
US6331205B1 (en) * 1997-08-08 2001-12-18 Laurence Paris Aqueous viscous compositions, whether clear or not, for making soft or hard capsules, and method for making films for such capsules
US6340473B1 (en) * 1999-07-07 2002-01-22 R.P. Scherer Technologies, Inc. Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
US6375981B1 (en) * 2000-06-01 2002-04-23 A. E. Staley Manufacturing Co. Modified starch as a replacement for gelatin in soft gel films and capsules
US6387354B1 (en) * 2000-03-06 2002-05-14 Shemberg Marketing Corporation Semi-refined carrageenan dentifrice binder
US20020122822A1 (en) * 2000-12-29 2002-09-05 Bunick Frank J. Process for preparing a soft tablet
US20020142031A1 (en) * 2000-06-01 2002-10-03 Gilleland G. M. Highly flexible starch-based films
US6479649B1 (en) * 2000-12-13 2002-11-12 Fmc Corporation Production of carrageenan and carrageenan products
US6517865B2 (en) * 1996-12-17 2003-02-11 Warner-Lambert Company Polymer film compositions for capsules
US20030084641A1 (en) * 2001-11-02 2003-05-08 Keith Tanner Encapsulation machine with valved injection wedge
US20030085487A1 (en) * 2001-11-02 2003-05-08 Keith Tanner Apparatus and method for manufacturing encapsulated products
US20030138482A1 (en) * 2002-01-18 2003-07-24 Fonkwe Linus G. Non-gelatin capsule shell formulation
US6607748B1 (en) * 2000-06-29 2003-08-19 Vincent Lenaerts Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
US6635275B1 (en) * 1999-01-29 2003-10-21 Warner-Lambert Company Modified starch film compositions
US20030211146A1 (en) * 1998-09-30 2003-11-13 Scott Robert A. Modified starch film compositions
US20040052839A1 (en) * 2002-01-18 2004-03-18 Archibald Don A. Non-gelatin film and method and apparatus for producing same
US6790495B1 (en) * 1999-11-19 2004-09-14 Peter Greither Method for manufacturing a shape body containing a starch, a homogenised mass containing starch and a device for manufacturing a soft capsule
US20040180083A1 (en) * 2001-07-05 2004-09-16 Sumihiro Shiraishi Soft capsules
US20050037064A1 (en) * 2001-12-27 2005-02-17 Ulice And Pierre Fabre Medicament Heteroxylan film-forming composition for making capsules and resulting capsules
US20050069579A1 (en) * 2001-11-22 2005-03-31 Ryosei Kamaguchi Non-gelatinous capsule film compositions and capsules using the same
US20050070703A1 (en) * 2001-10-23 2005-03-31 Rolf Muller Polysaccharide based network and method for the production thereof
US20050089548A1 (en) * 2001-11-16 2005-04-28 Virgalitto Margaret T. Edible film
US20050163833A1 (en) * 2001-10-23 2005-07-28 Rolf Muller Production of starch-gel-based shaped bodies

Family Cites Families (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US348669A (en) 1886-09-07 John p
US3460717A (en) * 1967-10-16 1969-08-12 Burger Chef Systems Inc Mixing assembly for a dispenser
US3849395A (en) * 1971-08-25 1974-11-19 Marine Colloids Inc Degraded modified seaweed extractive and compositions containing same and their production
US4231803A (en) 1978-05-22 1980-11-04 Anheuser-Busch Incorporated Starch adhesive composition containing an oxidized waxy starch ester
JPS56167703A (en) * 1980-04-09 1981-12-23 Fmc Corp Sea weed eucheumacottonii denatured extract
JPS6055039A (ja) * 1983-09-07 1985-03-29 Mitsubishi Acetate Co Ltd 水溶性多糖類フイルム
JPS6088047A (ja) 1983-10-21 1985-05-17 Kohjin Co Ltd 高吸収性ポリマ−組成物の製造方法
JPS6110508A (ja) * 1984-06-26 1986-01-18 Mitsubishi Acetate Co Ltd カプセル及びその製法
US4708834A (en) * 1986-05-01 1987-11-24 Pharmacaps, Inc. Preparation of gelatin-encapsulated controlled release composition
JPS63164858A (ja) * 1986-12-27 1988-07-08 Unie Koroido Kk 軟カプセルの外皮
US4851394A (en) * 1986-12-30 1989-07-25 Uni Colloid Kabushiki Kaisha Glucomannan/polyhydric alcohol composition and film prepared therefrom
US4808707A (en) * 1987-06-08 1989-02-28 University Of Delaware Chitosan alginate capsules
JPS6416563A (en) * 1987-07-10 1989-01-20 Toyo Suisan Kaisha Production of sheet-shaped food
JPH0259513A (ja) * 1988-08-24 1990-02-28 Kiyuukiyuu Yakuhin Kogyo Kk 口腔粘膜貼付型口臭防止剤
JPH02308760A (ja) * 1989-05-23 1990-12-21 Mitsubishi Rayon Co Ltd 可食性フイルム及びその製造方法
CA2020405C (en) 1989-07-11 2003-03-11 Jakob Silbiger Polymer base blend compositions containing destructurized starch
NO903089L (no) 1989-07-18 1991-01-21 Warner Lambert Co Polymere basisblandinger med strukturendret stivelse.
FI102480B (fi) 1989-07-18 1998-12-15 Warner Lambert Co Rakenteeltaan muunnettua tärkkelystä sisältävät polymeeriperustaiset s eoskoostumukset
YU136990A (sh) 1989-07-20 1992-09-07 Warner-Lambert Company Preparati polimernih smeša koji sadrže destrukturisani skrob
US5146730A (en) 1989-09-20 1992-09-15 Banner Gelatin Products Corp. Film-enrobed unitary-core medicament and the like
JPH0647530B2 (ja) * 1990-02-03 1994-06-22 ユニコロイド株式会社 腸疾患用薬剤カプセル及びその製法
DE4018247A1 (de) * 1990-06-07 1991-12-12 Lohmann Therapie Syst Lts Herstellungsverfahren fuer schnellzerfallende folienfoermige darreichungsformen
GB9017800D0 (en) 1990-08-14 1990-09-26 Unilever Plc Moisture barrier and its preparation
JPH04293460A (ja) * 1991-03-20 1992-10-19 Mitsubishi Rayon Co Ltd 多糖フィルムおよびその製造方法
JPH04372627A (ja) * 1991-06-20 1992-12-25 Mitsubishi Rayon Co Ltd 多糖フィルム
ES2109303T3 (es) 1991-12-16 1998-01-16 Nat Starch Chem Invest Peliculas comestibles.
JPH05308910A (ja) * 1992-05-01 1993-11-22 Osaka Kagaku Gokin Kk ヒートシール性の良好な耐水性可食フィルム
AU660824B2 (en) 1992-06-12 1995-07-06 Teijin Limited Pharmaceutical preparation for intra-airway administration
JPH0665048A (ja) * 1992-08-20 1994-03-08 Kibun Food Chemifa Co Ltd フィルム状パック剤
JP3116602B2 (ja) * 1992-10-06 2000-12-11 シオノギクオリカプス株式会社 硬質カプセル
GB9226392D0 (en) 1992-12-18 1993-02-10 Cpc International Inc Gelling agent
JPH07135913A (ja) * 1993-11-19 1995-05-30 Sanei Gen F F I Inc 多構造デザートゼリーの製造法
JP2567566B2 (ja) * 1994-03-01 1996-12-25 三栄源エフ・エフ・アイ株式会社 ドリンクゼリーの製造法
US5528088A (en) * 1994-06-27 1996-06-18 Amphenol Corporation Current mode coupler with improved grounding
JP2959423B2 (ja) 1994-12-01 1999-10-06 シオノギクオリカプス株式会社 カプセル用皮膜組成物
US5656294A (en) 1995-06-07 1997-08-12 Cibus Pharmaceutical, Inc. Colonic delivery of drugs
GB9606371D0 (en) * 1996-03-26 1996-06-05 Brown Malcolm D An encapsulation process
US6214375B1 (en) * 1996-07-16 2001-04-10 Generex Pharmaceuticals, Inc. Phospholipid formulations
DE19646392A1 (de) * 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
JPH10179045A (ja) * 1996-12-25 1998-07-07 Osaka Kagaku Gokin Kk シート状可食性成形物
US5813093A (en) * 1997-01-31 1998-09-29 Lucent Technologies Inc. Hinge assembly
JP3238350B2 (ja) 1997-05-27 2001-12-10 三粧化研株式会社 可食性パール状カプセルおよびその製造法
JP2931811B2 (ja) * 1997-06-03 1999-08-09 ユニコロイド株式会社 徐放性カプセル
JPH11130645A (ja) * 1997-10-29 1999-05-18 Lion Corp 歯周疾患治療用シート
US5962053A (en) * 1998-02-17 1999-10-05 Viskase Corporation Edible film and method
US6187293B1 (en) 1998-04-27 2001-02-13 Fmc Corporation Process for making toothpaste using low levels of carrageenan
JP3182393B2 (ja) * 1998-05-13 2001-07-03 三菱レイヨン株式会社 低温ゲル化用カラギーナン
KR20000011247A (ko) * 1998-07-23 2000-02-25 김윤 다당류를이용한대장선택성약물전달조성물및약학제제
US6268191B1 (en) * 1998-09-21 2001-07-31 Robert K. Prud'homme Enzyme immobilization by imbibing an enzyme solution into dehydrated hydrocolloid gel beads
US20030206942A1 (en) * 1998-09-25 2003-11-06 Neema Kulkarni Fast dissolving orally consumable films containing an antitussive and a mucosa coating agent
US6596298B2 (en) * 1998-09-25 2003-07-22 Warner-Lambert Company Fast dissolving orally comsumable films
JP2000125801A (ja) 1998-10-22 2000-05-09 Japan Tobacco Inc 節類の顆粒
GB9824658D0 (en) * 1998-11-11 1999-01-06 Brown Malcolm D A capsule based drug delivery system
WO2000027367A1 (en) 1998-11-11 2000-05-18 Bioprogress Technology International Incorporated A capsule based drug delivery system
US6432448B1 (en) * 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
NZ514994A (en) 1999-05-12 2003-05-30 Cp Kelco Aps Food composition with high solids content, a method for its preparation as well as the use of carrageenans for gelling a food composition
MXPA02000272A (es) * 1999-07-06 2002-06-21 Procter & Gamble Dispositivos en lamina pre-formados, auto-adhesivos para aplicacion topica.
US6500462B1 (en) * 1999-10-29 2002-12-31 Fmc Corporation Edible MCC/PGA coating composition
ES2217000T5 (es) * 1999-12-09 2009-10-01 Comvita Limited Apositos medicos que comprenden miel gelificada.
US7067116B1 (en) * 2000-03-23 2006-06-27 Warner-Lambert Company Llc Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1
JP3481580B2 (ja) * 2000-04-11 2003-12-22 三栄源エフ・エフ・アイ株式会社 弾性食品組成物及びその製造方法
US6497887B1 (en) * 2000-04-13 2002-12-24 Color Access, Inc. Membrane delivery system
WO2002038132A2 (de) 2000-11-09 2002-05-16 Celanese Ventures Gmbh Weichkapseln umfassend ein stärkegemisch verringerten verzweigungsgrades
TR200300731T2 (tr) * 2000-11-28 2004-08-23 Fmc Corporation Yenebilir PGA kaplama bileşimi
US20020131990A1 (en) * 2000-11-30 2002-09-19 Barkalow David G. Pullulan free edible film compositions and methods of making the same
JP2002186427A (ja) * 2000-12-19 2002-07-02 Sanei Gen Ffi Inc 冷 菓
JP4336875B2 (ja) * 2001-03-19 2009-09-30 大正製薬株式会社 ゲル組成物
US7293910B2 (en) * 2001-05-24 2007-11-13 Masco Corporation Surge suppressor for a mixer head assembly
US8309118B2 (en) 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
WO2003030881A1 (en) * 2001-10-12 2003-04-17 Kosmos Pharma Glucan based film delivery systems
JP2003125714A (ja) * 2001-10-29 2003-05-07 Ina Food Ind Co Ltd カプセル基材及びそれからなるカプセル、並びにカプセル基材の製造方法
JP2003192615A (ja) * 2001-12-26 2003-07-09 Nissei Kosan Kk カプセル剤の製法
JP2003199809A (ja) * 2002-01-09 2003-07-15 Toyo Capsule Kk 軟カプセルシェル
NO20021592D0 (no) 2002-04-04 2002-04-04 Fmc Biopolymer As Polysakkaridkapsler og fremgangsmåte ved fremstilling derav
JP2003299714A (ja) 2002-04-10 2003-10-21 Fuji Capsule Kk 軟カプセル剤皮膜組成物
JP4000279B2 (ja) * 2002-05-29 2007-10-31 富士フイルム株式会社 記録テープカートリッジ
US20040013723A1 (en) * 2002-07-16 2004-01-22 PARIKH Rita M. Oral care capsules
GB0217382D0 (en) * 2002-07-26 2002-09-04 Pfizer Ltd Process for making orally consumable dosage forms
JP2004167084A (ja) 2002-11-21 2004-06-17 Ina Food Ind Co Ltd ソフトカプセル皮膜、その原料及びソフトカプセル
US6987182B2 (en) 2003-03-26 2006-01-17 North Carolina State University Process for producing cold-gelling hydrocolloids
US20040202698A1 (en) * 2003-04-02 2004-10-14 The Procter & Gamble Company Drug delivery systems comprising an encapsulated active ingredient
US20050019295A1 (en) * 2003-04-14 2005-01-27 Fmc Corporation Homogeneous, thermoreversible low viscosity polymannan gum films and soft capsules made therefrom
US20050013847A1 (en) * 2003-04-14 2005-01-20 Fmc Corporation Delivery systems of homogeneous, thermoreversible alginate films
US20050008677A1 (en) * 2003-04-14 2005-01-13 Fmc Corporation Delivery system of homogeneous, thermoreversible gel film containing kappa-2 carrageenan
US7816341B2 (en) * 2003-04-14 2010-10-19 Fmc Corporation Homogeneous, thermoreversible gel containing reduced viscosity carrageenan and products made therefrom
US20050048185A1 (en) * 2003-04-14 2005-03-03 Fmc Corporation Delivery systems of homogeneous, thermoreversible low viscosity polymannan gum films
BRPI0409329A (pt) * 2003-04-14 2006-04-25 Fmc Corp processo para fabricar pelìculas de gel termorreversìveis, homogêneas, pelìcula homogênea, termorreversìvel, de sólidos altos, umidade baixa, processo para fabricar cápsulas moles, cápsulas moles, processo para fabricar uma forma de dosagem sólida, forma sólida, processo para preparar uma sistema de liberação de pelìcula de gel homogênea, e, sistema de liberação
US20050019294A1 (en) * 2003-04-14 2005-01-27 Fmc Corporation Homogeneous, thermoreversible alginate films and soft capsules made therefrom

Patent Citations (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2813093A (en) * 1953-06-10 1957-11-12 Nat Starch Products Inc Ungelatinized tertiary amino alkyl ethers of amylaceous materials
US2802000A (en) * 1953-08-13 1957-08-06 Nat Starch Products Inc Ungelatinized cold water soluble starch ethers
US2825727A (en) * 1954-05-19 1958-03-04 Nat Starch Products Inc Ungelatinized starch products of improved properties and method of making the same
US2876217A (en) * 1956-12-31 1959-03-03 Corn Products Co Starch ethers containing nitrogen and process for making the same
US3094517A (en) * 1958-12-29 1963-06-18 Marine Colloids Inc Process for treating a polysaccharide of seaweeds of the gigartinaceae and solieriaceae families
US3329509A (en) * 1959-12-01 1967-07-04 Ile Des Produits Lifine Soc Ci Food wrapping membrane
US3058827A (en) * 1960-02-09 1962-10-16 Eastman Kodak Co Dialdehyde starch as gelatin hardener
US3176003A (en) * 1961-08-15 1965-03-30 Marine Colloids Inc Selective extraction of hydrocolloid fractions from sea plants
US3378546A (en) * 1965-03-03 1968-04-16 American Maize Prod Co Hydroxypropyl starch ether
US3505110A (en) * 1967-01-18 1970-04-07 Penick & Ford Ltd Sugar products prepared from hydroxypropylated starch
US3499962A (en) * 1967-08-24 1970-03-10 Nat Starch Chem Corp Encapsulation of water insoluble materials
US3607394A (en) * 1969-05-29 1971-09-21 Felix Joseph Germino Novel pregelatinized starches and process for preparing same
US3865603A (en) * 1972-07-17 1975-02-11 Nat Starch Chem Corp Modified starch-extended gelatin compositions
US4009291A (en) * 1974-03-25 1977-02-22 General Foods Corporation Cold water soluble stable bulked starch
US3956173A (en) * 1974-07-05 1976-05-11 Hercules Incorporated Preparation of gels based on carrageenan
US3962482A (en) * 1975-03-24 1976-06-08 Uniroyal, Ltd. Clear, elastic, water gels based on carrageenan
US4129134A (en) * 1975-04-14 1978-12-12 Philip Morris Incorporated Smoking article
US4026986A (en) * 1975-05-22 1977-05-31 The Dow Chemical Company Capsule shell
US4096327A (en) * 1977-01-05 1978-06-20 Fmc Corporation Modified kappa-carrageenan
US4276320A (en) * 1980-01-25 1981-06-30 Fmc Corporation Compositions and method for preparing dessert gels
US4443486A (en) * 1980-04-09 1984-04-17 Fmc Corporation Modified extractive of Eucheuma cottonii seaweed and composition containing same
US4632848A (en) * 1981-06-23 1986-12-30 Roquette Freres Composition and process for forming a temporary protective coating on an article and article so-protected
US4600439A (en) * 1982-10-12 1986-07-15 Roquette Freres Composition and process for coating paper and cardboard process for preparing the compositions and paper and cardboard so obtained
US4738724A (en) * 1983-11-04 1988-04-19 Warner-Lambert Company Method for forming pharmaceutical capsules from starch compositions
US4643894A (en) * 1984-07-24 1987-02-17 Colorcon, Inc. Maltodextrin coating
US4725441A (en) * 1984-07-24 1988-02-16 Colorcon, Inc. Maltodextrin coating
US4828841A (en) * 1984-07-24 1989-05-09 Colorcon, Inc. Maltodextrin coating
US4626288A (en) * 1985-01-10 1986-12-02 National Starch And Chemical Corporation Starch derivatives forming reversible gels
US4615897A (en) * 1985-02-25 1986-10-07 Nabisco Brands, Inc. Cold water soluble gelatin
US4795642A (en) * 1986-05-01 1989-01-03 Pharmacaps, Inc. Gelatin-encapsulated controlled-release composition
US5002934A (en) * 1986-11-24 1991-03-26 Van Den Bergh Foods Co., Division Of Conopco, Inc. Aqueous gel comprising carrageenan
US5051304A (en) * 1986-12-18 1991-09-24 Societe Anonyme: Mero Rousselot Satia Microcapsules based on gelatin and polysaccharides and process for obtaining same
US4935243A (en) * 1988-12-19 1990-06-19 Pharmacaps, Inc. Chewable, edible soft gelatin capsule
US5525368A (en) * 1989-02-10 1996-06-11 Alko Group Ltd. Degraded polysaccharide derivatives and foodstuffs containing same
US5089307A (en) * 1989-05-23 1992-02-18 Mitsubishi Rayon Co., Ltd. Edible film and method of making same
US5620757A (en) * 1989-05-23 1997-04-15 Mitsubishi Rayon Co., Ltd. Edible film and method of making same
US5264223A (en) * 1990-03-29 1993-11-23 Japan Elanco Company, Ltd. Hard capsule for pharmaceutical drugs and method for producing the same
US5554385A (en) * 1990-11-28 1996-09-10 R. P. Scherer Corporation High amylose starch substituted gelatin capsules
US5224989A (en) * 1991-11-18 1993-07-06 Eva Likarova Film-forming dispersion for a protective coating of drug and food containing articles and objects
US5587412A (en) * 1992-03-31 1996-12-24 National Starch And Chemical Investment Holding Corporation Esterified starch composition
US5550178A (en) * 1992-04-08 1996-08-27 Vivorx, Inc. Process for encapsulating biologics using crosslinkable biocompatible encapsulation system
US5334640A (en) * 1992-04-08 1994-08-02 Clover Consolidated, Ltd. Ionically covalently crosslinked and crosslinkable biocompatible encapsulation compositions and methods
US5484598A (en) * 1992-08-18 1996-01-16 R.P. Scherer Corporation Soft gelatin medicament capsules with gripping construction
US5431917A (en) * 1992-10-08 1995-07-11 Japan Elanco Company, Ltd. Hard capsule for pharmaceutical drugs and method for producing the same
US5451673A (en) * 1993-04-23 1995-09-19 The United States Of America As Represented By The Secretary Of Agriculture Films fabricated from mixtures of pectin and starch
US5646206A (en) * 1993-04-23 1997-07-08 The United States Of America As Represented By The Secretary Of Agriculture Films fabricated from mixtures of pectin and poly(vinyl alchohol)
US5342626A (en) * 1993-04-27 1994-08-30 Merck & Co., Inc. Composition and process for gelatin-free soft capsules
US5817323A (en) * 1993-06-28 1998-10-06 R.P. Scherer Corporation Soft gelatin capsule shell compositions
US6099876A (en) * 1994-10-11 2000-08-08 Yissum Research Development Co. Of The Hebrew University Of Jerusalem Temperature-stable liquid cells
US5756123A (en) * 1994-12-01 1998-05-26 Japan Elanco Co., Ltd. Capsule shell
US5804243A (en) * 1994-12-23 1998-09-08 Cpc International Inc. Process for making low-fat, cake donuts
US5569466A (en) * 1995-05-17 1996-10-29 R. P. Scherer Corporation Fill compositions for soft elastic gel capsules
US5811388A (en) * 1995-06-07 1998-09-22 Cibus Pharmaceutical, Inc. Delivery of drugs to the lower GI tract
US5614217A (en) * 1995-06-07 1997-03-25 R.P. Scherer Corporation Capsule shell formulation to produce brittle capsules
US5672699A (en) * 1995-09-06 1997-09-30 National Starch And Chemical Investment Holding Corporation Process for preparation of hydrophobic starch derivatives
US5549983A (en) * 1996-01-22 1996-08-27 Alliedsignal Inc. Coflow planar fuel cell stack construction for solid electrolytes
US5932639A (en) * 1996-05-06 1999-08-03 National Starch And Chemical Investment Holding Corporation Maltodextrin-based adhesives
US5820259A (en) * 1996-07-30 1998-10-13 Q-Jet Dsi, Inc. Dual control mixing jet cooker
US5726008A (en) * 1996-09-18 1998-03-10 Eastman Kodak Company Photographic elements with improved vehicles
US6517865B2 (en) * 1996-12-17 2003-02-11 Warner-Lambert Company Polymer film compositions for capsules
US5945126A (en) * 1997-02-13 1999-08-31 Oakwood Laboratories L.L.C. Continuous microsphere process
US5976586A (en) * 1997-03-10 1999-11-02 Lawrence Foods Glaze composition with vegetable gums
US6030641A (en) * 1997-06-03 2000-02-29 Uni Colloid Kabushiki Kaisha Sustained release capsule and method for preparing the same
US6331205B1 (en) * 1997-08-08 2001-12-18 Laurence Paris Aqueous viscous compositions, whether clear or not, for making soft or hard capsules, and method for making films for such capsules
US6326028B1 (en) * 1997-10-31 2001-12-04 Monsanto Company Alginate and gellan gum as tablet coating
US6066368A (en) * 1997-12-30 2000-05-23 National Starch And Chemical Investment Holding Corporation Starch esters as moisture vapor barrier coatings
US6143324A (en) * 1998-02-03 2000-11-07 Cerestar Holdings B.V. Free-flowable directly compressible starch as binder, disintegrant and filler for compression tablets and hard gelatine capsules
US6146570A (en) * 1998-03-20 2000-11-14 Rhodia Inc. Process for producing extruded hydrocolloid granules
US6063915A (en) * 1998-07-30 2000-05-16 Hercules Incorporated Carrageenan compositions and methods for their production
US6214376B1 (en) * 1998-08-25 2001-04-10 Banner Pharmacaps, Inc. Non-gelatin substitutes for oral delivery capsules, their composition and process of manufacture
US20030211146A1 (en) * 1998-09-30 2003-11-13 Scott Robert A. Modified starch film compositions
US6635275B1 (en) * 1999-01-29 2003-10-21 Warner-Lambert Company Modified starch film compositions
US6210709B1 (en) * 1999-03-24 2001-04-03 Elementis Specialties, Inc. Flexible gelatin free encapsulation material useful for pharmaceuticals, paint balls and other formulations
US6340473B1 (en) * 1999-07-07 2002-01-22 R.P. Scherer Technologies, Inc. Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
US20020081331A1 (en) * 1999-07-07 2002-06-27 R.P. Scherer Technologies, Inc. Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
US6582727B2 (en) * 1999-07-07 2003-06-24 R. P. Scherer Technologies, Inc. Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
US6790495B1 (en) * 1999-11-19 2004-09-14 Peter Greither Method for manufacturing a shape body containing a starch, a homogenised mass containing starch and a device for manufacturing a soft capsule
US6387354B1 (en) * 2000-03-06 2002-05-14 Shemberg Marketing Corporation Semi-refined carrageenan dentifrice binder
US6528088B1 (en) * 2000-06-01 2003-03-04 A. E. Staley Manufacturing Co. Highly flexible starch-based films
US6375981B1 (en) * 2000-06-01 2002-04-23 A. E. Staley Manufacturing Co. Modified starch as a replacement for gelatin in soft gel films and capsules
US6649188B2 (en) * 2000-06-01 2003-11-18 A. E. Staley Manufacturing Co. Highly flexible starch-based films
US20020142031A1 (en) * 2000-06-01 2002-10-03 Gilleland G. M. Highly flexible starch-based films
US6607748B1 (en) * 2000-06-29 2003-08-19 Vincent Lenaerts Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
US6479649B1 (en) * 2000-12-13 2002-11-12 Fmc Corporation Production of carrageenan and carrageenan products
US20020122822A1 (en) * 2000-12-29 2002-09-05 Bunick Frank J. Process for preparing a soft tablet
US20040180083A1 (en) * 2001-07-05 2004-09-16 Sumihiro Shiraishi Soft capsules
US20050163833A1 (en) * 2001-10-23 2005-07-28 Rolf Muller Production of starch-gel-based shaped bodies
US20050070703A1 (en) * 2001-10-23 2005-03-31 Rolf Muller Polysaccharide based network and method for the production thereof
US20030085487A1 (en) * 2001-11-02 2003-05-08 Keith Tanner Apparatus and method for manufacturing encapsulated products
US20030084641A1 (en) * 2001-11-02 2003-05-08 Keith Tanner Encapsulation machine with valved injection wedge
US20050089548A1 (en) * 2001-11-16 2005-04-28 Virgalitto Margaret T. Edible film
US20050069579A1 (en) * 2001-11-22 2005-03-31 Ryosei Kamaguchi Non-gelatinous capsule film compositions and capsules using the same
US20050037064A1 (en) * 2001-12-27 2005-02-17 Ulice And Pierre Fabre Medicament Heteroxylan film-forming composition for making capsules and resulting capsules
US20040052839A1 (en) * 2002-01-18 2004-03-18 Archibald Don A. Non-gelatin film and method and apparatus for producing same
US20030138482A1 (en) * 2002-01-18 2003-07-24 Fonkwe Linus G. Non-gelatin capsule shell formulation

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050196436A1 (en) * 2004-03-02 2005-09-08 Arjnarong Chantranukul Blends of different acyl gellan gums and starch
US20050196437A1 (en) * 2004-03-02 2005-09-08 Bednarz Christina A. Hard capsules
US7494667B2 (en) 2004-03-02 2009-02-24 Brunob Ii B.V. Blends of different acyl gellan gums and starch
US8262820B2 (en) 2006-04-28 2012-09-11 United States Gypsum Company Method of water dispersing pregelatinized starch in making gypsum products
US20080138402A1 (en) * 2006-11-17 2008-06-12 Zhixin Li Highly inhibited starch fillers for films and capsules
US8574624B2 (en) 2006-11-17 2013-11-05 Corn Products Development, Inc. Highly inhibited starch fillers for films and capsules
US20090217462A1 (en) * 2008-02-08 2009-09-03 Holzhauer Fred Consumer product packets with enhanced performance
US8236747B2 (en) 2008-02-08 2012-08-07 Method Products, Inc. Consumer product packets with enhanced performance
US20090249562A1 (en) * 2008-04-02 2009-10-08 Mark Robert Sivik Fabric color rejuvenation composition
US20100061180A1 (en) * 2008-09-05 2010-03-11 United States Gypsum Company Efficient wet starch preparation system for gypsum board production
US8303159B2 (en) 2008-09-05 2012-11-06 United States Gypsum Company Efficient wet starch preparation system for gypsum board production

Also Published As

Publication number Publication date
KR20060003350A (ko) 2006-01-10
WO2004091532A3 (en) 2006-05-18
JP2007526211A (ja) 2007-09-13
CA2522296A1 (en) 2004-10-28
US20080089934A1 (en) 2008-04-17
JP2006524743A (ja) 2006-11-02
EP1617825A2 (de) 2006-01-25
WO2004091533A2 (en) 2004-10-28
US20050019374A1 (en) 2005-01-27
BRPI0409357B8 (pt) 2021-05-25
EP1620114A2 (de) 2006-02-01
KR20060011954A (ko) 2006-02-06
WO2004091537B1 (en) 2005-07-14
BRPI0409329A (pt) 2006-04-25
JP2007526209A (ja) 2007-09-13
CA2522293A1 (en) 2004-10-28
EP1617815A2 (de) 2006-01-25
WO2004091527B1 (en) 2005-10-06
WO2004091529A3 (en) 2005-02-24
BRPI0409357A (pt) 2006-04-25
WO2004091537A3 (en) 2005-05-06
EP1622594A2 (de) 2006-02-08
WO2004091539A2 (en) 2004-10-28
JP4558721B2 (ja) 2010-10-06
WO2004091530B1 (en) 2005-04-21
JP2007526210A (ja) 2007-09-13
WO2004091528B1 (en) 2005-03-24
CA2522297A1 (en) 2004-10-28
BRPI0409342A (pt) 2006-04-25
JP2006526057A (ja) 2006-11-16
EP1622594A4 (de) 2010-07-14
EP1628620A4 (de) 2010-01-06
KR20060011953A (ko) 2006-02-06
EP1628643A2 (de) 2006-03-01
EP1622588A2 (de) 2006-02-08
KR20060011955A (ko) 2006-02-06
BRPI0409343A (pt) 2006-04-25
IL171291A (en) 2010-12-30
PL1628643T3 (pl) 2013-09-30
WO2004091528A3 (en) 2005-01-27
BRPI0409336A (pt) 2006-04-25
BRPI0409357B1 (pt) 2018-02-06
EP1628643B1 (de) 2013-02-27
WO2004091527A3 (en) 2005-08-18
WO2004091529B1 (en) 2005-05-19
WO2004091538A2 (en) 2004-10-28
KR101128201B1 (ko) 2012-03-23
WO2004091532A2 (en) 2004-10-28
WO2004091533A3 (en) 2006-05-18
EP1628620A2 (de) 2006-03-01
EP1628643A4 (de) 2010-01-06
US7807194B2 (en) 2010-10-05
WO2004091528A2 (en) 2004-10-28
JP2007525551A (ja) 2007-09-06
EP1620059A2 (de) 2006-02-01
WO2004091530A2 (en) 2004-10-28
WO2004091538A3 (en) 2005-04-07
WO2004091539A3 (en) 2005-05-06
MXPA05011028A (es) 2005-12-12
JP4602326B2 (ja) 2010-12-22
WO2004091538B1 (en) 2005-05-26
CA2522295C (en) 2012-02-07
CA2522298A1 (en) 2004-10-28
WO2004091527A2 (en) 2004-10-28
JP2007525451A (ja) 2007-09-06
JP2007528357A (ja) 2007-10-11
BRPI0409345A (pt) 2006-04-25
EP1628643B9 (de) 2013-06-12
CA2522295A1 (en) 2004-10-28
MXPA05011027A (es) 2005-12-12
WO2004091529A2 (en) 2004-10-28
MXPA05011026A (es) 2005-12-12
WO2004091530A3 (en) 2005-03-03
BRPI0409334A (pt) 2006-04-25
MXPA05011029A (es) 2005-12-12
WO2004091537A2 (en) 2004-10-28

Similar Documents

Publication Publication Date Title
US20050084516A1 (en) Process for making gel films
US7816341B2 (en) Homogeneous, thermoreversible gel containing reduced viscosity carrageenan and products made therefrom
US20090208569A1 (en) Homogeneous, Thermoreversible Alginate Films and Soft Capsules Made Therefrom
ZA200508251B (en) Homogeneous, thermoreversible gel film containing kappa-2 carrageenan and soft capsules made therefrom
US20050013847A1 (en) Delivery systems of homogeneous, thermoreversible alginate films
US20050008677A1 (en) Delivery system of homogeneous, thermoreversible gel film containing kappa-2 carrageenan
US20050019295A1 (en) Homogeneous, thermoreversible low viscosity polymannan gum films and soft capsules made therefrom
RU2341250C2 (ru) Гомогенная термообратимая гелевая пленка, содержащая каппа-2-каррагинан, и полученные из нее мягкие капсулы
US20050048185A1 (en) Delivery systems of homogeneous, thermoreversible low viscosity polymannan gum films
RU2341290C2 (ru) Гомогенный, термически обратимый гель, содержащий каррагенан пониженной вязкости, и продукты, изготовленные из него
ZA200508253B (en) Homogeneous, thermoreversible alginate films and soft capsules made therefrom

Legal Events

Date Code Title Description
AS Assignment

Owner name: FMC CORPORATION, PENNSYLVANIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BALLARD, ARTHUR D.;SEWALL, CHRISTOPHER J.;MODLISZEWSKI, JAMES J.;AND OTHERS;REEL/FRAME:018278/0838;SIGNING DATES FROM 20040805 TO 20040810